<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bf8cd36e-43d4-4ffe-a4f4-3f834c15a0af,g:1c9b7250-2651-4a6d-a1ff-d1ec5bc6d018-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ivericbio.com/role/Cover" xlink:type="simple" xlink:href="isee-20220630.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_84558ece-c6a8-43f7-b924-281694543358" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_DocumentType_84558ece-c6a8-43f7-b924-281694543358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_439cabc3-ee9b-4cae-b9b8-6b4c0fbade0e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_DocumentQuarterlyReport_439cabc3-ee9b-4cae-b9b8-6b4c0fbade0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_bfb48d7d-6305-4fe5-a8d6-74b5765aed93" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_DocumentPeriodEndDate_bfb48d7d-6305-4fe5-a8d6-74b5765aed93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_55c0037c-53ad-451c-800b-ee89a0eed6c9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_DocumentTransitionReport_55c0037c-53ad-451c-800b-ee89a0eed6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_254a9b58-e7f8-4d5e-928c-a5c161e69d21" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_EntityFileNumber_254a9b58-e7f8-4d5e-928c-a5c161e69d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_6fae333a-b6b8-4d79-9dbb-5ab6832d8692" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_EntityRegistrantName_6fae333a-b6b8-4d79-9dbb-5ab6832d8692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_3575b85c-bfaf-4f9a-a09a-6f4ead67787e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_EntityIncorporationStateCountryCode_3575b85c-bfaf-4f9a-a09a-6f4ead67787e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8b8330c5-7d39-4ae3-978c-bd505942452b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_EntityTaxIdentificationNumber_8b8330c5-7d39-4ae3-978c-bd505942452b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_807e53d3-d531-4270-b261-e34f126fe014" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_EntityAddressAddressLine1_807e53d3-d531-4270-b261-e34f126fe014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c1054c25-72d9-44de-91e4-fa840ea3ff20" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_EntityAddressPostalZipCode_c1054c25-72d9-44de-91e4-fa840ea3ff20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_3220911d-d44c-449a-a1ab-f8b03aecf81c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_EntityAddressCityOrTown_3220911d-d44c-449a-a1ab-f8b03aecf81c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_5257858d-125b-4aab-8274-ba395c4d1211" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_EntityAddressStateOrProvince_5257858d-125b-4aab-8274-ba395c4d1211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ece478f7-5e98-485e-bc0e-a3111beb957f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_CityAreaCode_ece478f7-5e98-485e-bc0e-a3111beb957f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f32e4e1e-0aff-40d1-8a7d-d5732d769fde" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_LocalPhoneNumber_f32e4e1e-0aff-40d1-8a7d-d5732d769fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9451cae2-7712-4389-8292-133204ec2826" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_Security12bTitle_9451cae2-7712-4389-8292-133204ec2826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_be73b135-a7e1-4bbb-8d87-42e29da66241" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_TradingSymbol_be73b135-a7e1-4bbb-8d87-42e29da66241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_abb6f6f9-3bf0-4138-b859-034954c05a03" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_SecurityExchangeName_abb6f6f9-3bf0-4138-b859-034954c05a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_e4be87ff-d9aa-4262-9c55-09304657d733" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_EntityCurrentReportingStatus_e4be87ff-d9aa-4262-9c55-09304657d733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_1a777a38-4b9b-4cec-ba65-5db333152569" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_EntityInteractiveDataCurrent_1a777a38-4b9b-4cec-ba65-5db333152569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_82255abc-7546-4568-b70e-5898b1f7eb77" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_EntityFilerCategory_82255abc-7546-4568-b70e-5898b1f7eb77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_156395a3-07b4-40a2-aa0b-2556fa1aa8fd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_EntitySmallBusiness_156395a3-07b4-40a2-aa0b-2556fa1aa8fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_6c0fdd36-13f6-4f02-aaff-e9a8ddd51b22" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_EntityEmergingGrowthCompany_6c0fdd36-13f6-4f02-aaff-e9a8ddd51b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_f337c3a3-1a5f-4b0c-bc88-735211868359" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_EntityShellCompany_f337c3a3-1a5f-4b0c-bc88-735211868359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_d7afffca-d617-4ba0-90cb-aaf13d901483" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_d7afffca-d617-4ba0-90cb-aaf13d901483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_b94bf603-a227-49ae-b3c1-587c21ae0dc9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_EntityCentralIndexKey_b94bf603-a227-49ae-b3c1-587c21ae0dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b0f89eb9-b38b-4a1b-b311-67e744821163" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_AmendmentFlag_b0f89eb9-b38b-4a1b-b311-67e744821163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_2fd8fea5-a0f0-4895-bae3-fa3bfdfbcc08" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_CurrentFiscalYearEndDate_2fd8fea5-a0f0-4895-bae3-fa3bfdfbcc08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_cdd15ca8-9a32-4c57-8e3a-1358a04b8a9e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_DocumentFiscalYearFocus_cdd15ca8-9a32-4c57-8e3a-1358a04b8a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_e5c8829e-6116-4768-aad6-6da3d2f10da3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec33b322-09c8-4bda-88bf-c873c869c906" xlink:to="loc_dei_DocumentFiscalPeriodFocus_e5c8829e-6116-4768-aad6-6da3d2f10da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CondensedUnauditedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="isee-20220630.xsd#CondensedUnauditedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CondensedUnauditedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_414d4619-7ba4-4ce8-83f2-77e4b318ada4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ffe0c842-220e-4b2f-b38a-642263370a41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_414d4619-7ba4-4ce8-83f2-77e4b318ada4" xlink:to="loc_us-gaap_AssetsAbstract_ffe0c842-220e-4b2f-b38a-642263370a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_a25be9f9-0e36-4b8b-9fd4-4191143de3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ffe0c842-220e-4b2f-b38a-642263370a41" xlink:to="loc_us-gaap_AssetsCurrentAbstract_a25be9f9-0e36-4b8b-9fd4-4191143de3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9b8b629d-bf4b-4574-9697-23a660db33b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a25be9f9-0e36-4b8b-9fd4-4191143de3c6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9b8b629d-bf4b-4574-9697-23a660db33b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_dda1f883-5d2a-4de1-b2cb-7f0e726f0292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a25be9f9-0e36-4b8b-9fd4-4191143de3c6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_dda1f883-5d2a-4de1-b2cb-7f0e726f0292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a95f635d-f34e-4f87-ba02-e79c51956428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a25be9f9-0e36-4b8b-9fd4-4191143de3c6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a95f635d-f34e-4f87-ba02-e79c51956428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_33e8955e-9b8a-4d44-b6b5-f5e6efd064f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a25be9f9-0e36-4b8b-9fd4-4191143de3c6" xlink:to="loc_us-gaap_AssetsCurrent_33e8955e-9b8a-4d44-b6b5-f5e6efd064f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9873a5e3-6e2d-424d-bdcd-f21fb1fc2a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ffe0c842-220e-4b2f-b38a-642263370a41" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9873a5e3-6e2d-424d-bdcd-f21fb1fc2a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a8de06ca-5868-449b-ad5b-fbc168853bee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ffe0c842-220e-4b2f-b38a-642263370a41" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a8de06ca-5868-449b-ad5b-fbc168853bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_4f8c197e-51fb-4891-bad7-81fa8a4b5fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ffe0c842-220e-4b2f-b38a-642263370a41" xlink:to="loc_us-gaap_Assets_4f8c197e-51fb-4891-bad7-81fa8a4b5fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c5c417b9-3429-41ab-8553-792099dd60d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_414d4619-7ba4-4ce8-83f2-77e4b318ada4" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c5c417b9-3429-41ab-8553-792099dd60d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_0e1e560d-5ed7-4455-93ce-8af9ab1d0faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c5c417b9-3429-41ab-8553-792099dd60d8" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_0e1e560d-5ed7-4455-93ce-8af9ab1d0faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AccruedResearchAndDevelopment_255010a0-5c98-44d5-8d71-9fa72034e4f3" xlink:href="isee-20220630.xsd#isee_AccruedResearchAndDevelopment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0e1e560d-5ed7-4455-93ce-8af9ab1d0faa" xlink:to="loc_isee_AccruedResearchAndDevelopment_255010a0-5c98-44d5-8d71-9fa72034e4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_073d7a18-aa5f-4950-9d50-9d56bb096910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0e1e560d-5ed7-4455-93ce-8af9ab1d0faa" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_073d7a18-aa5f-4950-9d50-9d56bb096910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_acbaa531-a554-4ed7-b9a6-2ee9cfd86674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0e1e560d-5ed7-4455-93ce-8af9ab1d0faa" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_acbaa531-a554-4ed7-b9a6-2ee9cfd86674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_839e221f-5b12-4cd9-984d-33fcab7a01f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0e1e560d-5ed7-4455-93ce-8af9ab1d0faa" xlink:to="loc_us-gaap_LiabilitiesCurrent_839e221f-5b12-4cd9-984d-33fcab7a01f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_dee5b767-e85f-444d-9393-edfe09dce5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c5c417b9-3429-41ab-8553-792099dd60d8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_dee5b767-e85f-444d-9393-edfe09dce5a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_52474ecc-3a55-4629-8ec8-e3b0cb6a41cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c5c417b9-3429-41ab-8553-792099dd60d8" xlink:to="loc_us-gaap_Liabilities_52474ecc-3a55-4629-8ec8-e3b0cb6a41cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_a9bdbcce-d522-4a20-aab7-ad6edfa91e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c5c417b9-3429-41ab-8553-792099dd60d8" xlink:to="loc_us-gaap_StockholdersEquityAbstract_a9bdbcce-d522-4a20-aab7-ad6edfa91e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_335ffcc4-81ca-47c7-9616-68ba71931dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a9bdbcce-d522-4a20-aab7-ad6edfa91e8b" xlink:to="loc_us-gaap_PreferredStockValue_335ffcc4-81ca-47c7-9616-68ba71931dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_9c00766c-ce75-4724-ac12-5aa194c054eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a9bdbcce-d522-4a20-aab7-ad6edfa91e8b" xlink:to="loc_us-gaap_CommonStockValue_9c00766c-ce75-4724-ac12-5aa194c054eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_fccfbcd3-9b10-4cfb-8115-76443fe6f87d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a9bdbcce-d522-4a20-aab7-ad6edfa91e8b" xlink:to="loc_us-gaap_AdditionalPaidInCapital_fccfbcd3-9b10-4cfb-8115-76443fe6f87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fced7b50-667d-4c5d-b420-27bddc7d154e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a9bdbcce-d522-4a20-aab7-ad6edfa91e8b" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fced7b50-667d-4c5d-b420-27bddc7d154e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_da966bf3-3cbf-4de6-89ef-caca334b1a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a9bdbcce-d522-4a20-aab7-ad6edfa91e8b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_da966bf3-3cbf-4de6-89ef-caca334b1a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a64b4824-f39d-43fa-9322-e4c976594ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a9bdbcce-d522-4a20-aab7-ad6edfa91e8b" xlink:to="loc_us-gaap_StockholdersEquity_a64b4824-f39d-43fa-9322-e4c976594ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_0cbc6a5a-534d-4ae0-b306-1a5b5013e9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c5c417b9-3429-41ab-8553-792099dd60d8" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_0cbc6a5a-534d-4ae0-b306-1a5b5013e9c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CondensedUnauditedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="isee-20220630.xsd#CondensedUnauditedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CondensedUnauditedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_bf58f3c7-028b-484b-8935-023c62cc64a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1334fe83-fbdf-4286-8270-7dd0b37d6a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bf58f3c7-028b-484b-8935-023c62cc64a1" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1334fe83-fbdf-4286-8270-7dd0b37d6a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_05039308-7290-49f2-9261-58d3bd8738e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bf58f3c7-028b-484b-8935-023c62cc64a1" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_05039308-7290-49f2-9261-58d3bd8738e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_0e4a8e26-93e7-467a-9595-972425c79fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bf58f3c7-028b-484b-8935-023c62cc64a1" xlink:to="loc_us-gaap_PreferredStockSharesIssued_0e4a8e26-93e7-467a-9595-972425c79fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_1412b1fe-7782-428a-b58a-71a05a4ba576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bf58f3c7-028b-484b-8935-023c62cc64a1" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_1412b1fe-7782-428a-b58a-71a05a4ba576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_671246fc-7981-4506-9617-64a05e82dfd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bf58f3c7-028b-484b-8935-023c62cc64a1" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_671246fc-7981-4506-9617-64a05e82dfd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_a160fdc2-c79c-4c2c-a654-daab94289710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bf58f3c7-028b-484b-8935-023c62cc64a1" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_a160fdc2-c79c-4c2c-a654-daab94289710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_cf678ecd-00ef-4a4d-9e58-609466e5725b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bf58f3c7-028b-484b-8935-023c62cc64a1" xlink:to="loc_us-gaap_CommonStockSharesIssued_cf678ecd-00ef-4a4d-9e58-609466e5725b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_08c75e46-feac-4866-971d-953a71ac5632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bf58f3c7-028b-484b-8935-023c62cc64a1" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_08c75e46-feac-4866-971d-953a71ac5632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CondensedUnauditedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="isee-20220630.xsd#CondensedUnauditedConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CondensedUnauditedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_isee_IncomeStatementAndStatementOfComprehensiveIncomeAbstract_2bfdc132-38d6-40de-969e-b04f59cf6fd8" xlink:href="isee-20220630.xsd#isee_IncomeStatementAndStatementOfComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_94c010c4-9655-4b86-ab71-a10a2691aacd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_IncomeStatementAndStatementOfComprehensiveIncomeAbstract_2bfdc132-38d6-40de-969e-b04f59cf6fd8" xlink:to="loc_us-gaap_OperatingExpensesAbstract_94c010c4-9655-4b86-ab71-a10a2691aacd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_833f1816-675c-4d2c-8e77-31b632ceb694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_94c010c4-9655-4b86-ab71-a10a2691aacd" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_833f1816-675c-4d2c-8e77-31b632ceb694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_5ec2ead3-01b2-4a79-b4a4-b4e47549764e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_94c010c4-9655-4b86-ab71-a10a2691aacd" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_5ec2ead3-01b2-4a79-b4a4-b4e47549764e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6438b23f-5b97-44d8-9b45-05bdb3701cef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_94c010c4-9655-4b86-ab71-a10a2691aacd" xlink:to="loc_us-gaap_OperatingExpenses_6438b23f-5b97-44d8-9b45-05bdb3701cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_63cb840c-bb80-4aaf-9d49-6f46a3a7f049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_IncomeStatementAndStatementOfComprehensiveIncomeAbstract_2bfdc132-38d6-40de-969e-b04f59cf6fd8" xlink:to="loc_us-gaap_OperatingIncomeLoss_63cb840c-bb80-4aaf-9d49-6f46a3a7f049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_22f36759-f85e-4152-b749-4835377477cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_IncomeStatementAndStatementOfComprehensiveIncomeAbstract_2bfdc132-38d6-40de-969e-b04f59cf6fd8" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_22f36759-f85e-4152-b749-4835377477cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ef63d41b-bef8-4722-9843-a2b40ae19044" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_IncomeStatementAndStatementOfComprehensiveIncomeAbstract_2bfdc132-38d6-40de-969e-b04f59cf6fd8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ef63d41b-bef8-4722-9843-a2b40ae19044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_080a2773-fa94-4576-8a2c-69b51e264011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_IncomeStatementAndStatementOfComprehensiveIncomeAbstract_2bfdc132-38d6-40de-969e-b04f59cf6fd8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_080a2773-fa94-4576-8a2c-69b51e264011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_dd224d3c-e380-47e3-b8bb-cd93133143a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_IncomeStatementAndStatementOfComprehensiveIncomeAbstract_2bfdc132-38d6-40de-969e-b04f59cf6fd8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_dd224d3c-e380-47e3-b8bb-cd93133143a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7a80b545-abfb-432f-9ecc-52d762af01b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_IncomeStatementAndStatementOfComprehensiveIncomeAbstract_2bfdc132-38d6-40de-969e-b04f59cf6fd8" xlink:to="loc_us-gaap_NetIncomeLoss_7a80b545-abfb-432f-9ecc-52d762af01b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b1cacd7d-73d8-4315-9331-de4a8eca798b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_IncomeStatementAndStatementOfComprehensiveIncomeAbstract_2bfdc132-38d6-40de-969e-b04f59cf6fd8" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_b1cacd7d-73d8-4315-9331-de4a8eca798b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_81332489-36de-4318-94bc-90538688d57c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_IncomeStatementAndStatementOfComprehensiveIncomeAbstract_2bfdc132-38d6-40de-969e-b04f59cf6fd8" xlink:to="loc_us-gaap_EarningsPerShareAbstract_81332489-36de-4318-94bc-90538688d57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_5a39e873-419a-4721-90ed-fc96f349f5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_81332489-36de-4318-94bc-90538688d57c" xlink:to="loc_us-gaap_EarningsPerShareBasic_5a39e873-419a-4721-90ed-fc96f349f5f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_17073469-1f99-434b-8427-8e5cfa99412b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_81332489-36de-4318-94bc-90538688d57c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_17073469-1f99-434b-8427-8e5cfa99412b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8ae9ddbc-2c8e-4938-b536-fef99a0507b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_IncomeStatementAndStatementOfComprehensiveIncomeAbstract_2bfdc132-38d6-40de-969e-b04f59cf6fd8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8ae9ddbc-2c8e-4938-b536-fef99a0507b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4d5eedd3-e180-496a-af81-bd725575b17e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8ae9ddbc-2c8e-4938-b536-fef99a0507b0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4d5eedd3-e180-496a-af81-bd725575b17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ed9f9d92-7219-4a62-ba34-f9ce2df6c631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8ae9ddbc-2c8e-4938-b536-fef99a0507b0" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ed9f9d92-7219-4a62-ba34-f9ce2df6c631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CondensedUnauditedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="isee-20220630.xsd#CondensedUnauditedConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CondensedUnauditedConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_c0baadc2-fd05-4c3e-b990-1dd62f2206af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1ecbbff4-1e39-4071-b8ec-b0e6695f2edd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c0baadc2-fd05-4c3e-b990-1dd62f2206af" xlink:to="loc_us-gaap_StatementTable_1ecbbff4-1e39-4071-b8ec-b0e6695f2edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_187f8827-fa4c-4dcc-a4d9-4298c4299a80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1ecbbff4-1e39-4071-b8ec-b0e6695f2edd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_187f8827-fa4c-4dcc-a4d9-4298c4299a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_62b1a270-46d8-4945-ba96-fcbbd556bb95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_187f8827-fa4c-4dcc-a4d9-4298c4299a80" xlink:to="loc_us-gaap_EquityComponentDomain_62b1a270-46d8-4945-ba96-fcbbd556bb95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_708fe13e-2c93-4b75-b4eb-6961e99949df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_62b1a270-46d8-4945-ba96-fcbbd556bb95" xlink:to="loc_us-gaap_PreferredStockMember_708fe13e-2c93-4b75-b4eb-6961e99949df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_87d643de-755d-4c21-b84d-58bf0880fee2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_62b1a270-46d8-4945-ba96-fcbbd556bb95" xlink:to="loc_us-gaap_CommonStockMember_87d643de-755d-4c21-b84d-58bf0880fee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_619b80b6-708d-4288-a281-f03ca0a97298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_62b1a270-46d8-4945-ba96-fcbbd556bb95" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_619b80b6-708d-4288-a281-f03ca0a97298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_2b79b231-f2a9-4ff8-9dc0-6f3d82e10cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_62b1a270-46d8-4945-ba96-fcbbd556bb95" xlink:to="loc_us-gaap_RetainedEarningsMember_2b79b231-f2a9-4ff8-9dc0-6f3d82e10cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeMember_aae15a13-c247-4063-b37c-1b2528ab18f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_62b1a270-46d8-4945-ba96-fcbbd556bb95" xlink:to="loc_us-gaap_ComprehensiveIncomeMember_aae15a13-c247-4063-b37c-1b2528ab18f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a2c2013e-6959-43b3-942e-51f28e0460b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1ecbbff4-1e39-4071-b8ec-b0e6695f2edd" xlink:to="loc_us-gaap_StatementLineItems_a2c2013e-6959-43b3-942e-51f28e0460b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999a9a8f-d049-4a66-97e1-e7bc65867ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a2c2013e-6959-43b3-942e-51f28e0460b6" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999a9a8f-d049-4a66-97e1-e7bc65867ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_e191413b-a92c-4ee6-ad96-cbb498793cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999a9a8f-d049-4a66-97e1-e7bc65867ecd" xlink:to="loc_us-gaap_SharesIssued_e191413b-a92c-4ee6-ad96-cbb498793cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8baa5ff5-0ca8-4139-9b1a-e091aeeae355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999a9a8f-d049-4a66-97e1-e7bc65867ecd" xlink:to="loc_us-gaap_StockholdersEquity_8baa5ff5-0ca8-4139-9b1a-e091aeeae355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_18463476-44b9-4502-b966-292475f73cef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999a9a8f-d049-4a66-97e1-e7bc65867ecd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_18463476-44b9-4502-b966-292475f73cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_dc7970cd-8147-435a-8882-0d7c82061609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999a9a8f-d049-4a66-97e1-e7bc65867ecd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_dc7970cd-8147-435a-8882-0d7c82061609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3343463a-287c-4c71-9b3f-d768bde7f61b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999a9a8f-d049-4a66-97e1-e7bc65867ecd" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3343463a-287c-4c71-9b3f-d768bde7f61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_55c0c415-c43d-4ebb-8817-b6e10e89293d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999a9a8f-d049-4a66-97e1-e7bc65867ecd" xlink:to="loc_us-gaap_NetIncomeLoss_55c0c415-c43d-4ebb-8817-b6e10e89293d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_7f9caa5b-ee5f-4ffd-9a70-8147f52ed6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999a9a8f-d049-4a66-97e1-e7bc65867ecd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_7f9caa5b-ee5f-4ffd-9a70-8147f52ed6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_80e47284-d3db-4af2-ace7-f2d1f7d43686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999a9a8f-d049-4a66-97e1-e7bc65867ecd" xlink:to="loc_us-gaap_SharesIssued_80e47284-d3db-4af2-ace7-f2d1f7d43686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a6a6f803-497d-4689-a654-400cda5fecc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_999a9a8f-d049-4a66-97e1-e7bc65867ecd" xlink:to="loc_us-gaap_StockholdersEquity_a6a6f803-497d-4689-a654-400cda5fecc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CondensedUnauditedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="isee-20220630.xsd#CondensedUnauditedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CondensedUnauditedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_5dcc6aa4-5d33-4a84-a61b-ca1877ef05e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_dbb8cd81-1e18-48ae-8a5a-12ce043c70ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5dcc6aa4-5d33-4a84-a61b-ca1877ef05e8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_dbb8cd81-1e18-48ae-8a5a-12ce043c70ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f102d851-1af4-429c-8e76-1482ecdff370" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_dbb8cd81-1e18-48ae-8a5a-12ce043c70ff" xlink:to="loc_us-gaap_NetIncomeLoss_f102d851-1af4-429c-8e76-1482ecdff370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a31e9d21-ebf9-4ce2-acc9-2ea9698eb5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_dbb8cd81-1e18-48ae-8a5a-12ce043c70ff" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a31e9d21-ebf9-4ce2-acc9-2ea9698eb5c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_c50ea3aa-67a3-4261-9df1-2a210ab77466" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a31e9d21-ebf9-4ce2-acc9-2ea9698eb5c4" xlink:to="loc_us-gaap_Depreciation_c50ea3aa-67a3-4261-9df1-2a210ab77466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_2d0ca1ff-3389-4271-9921-2252842e8ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a31e9d21-ebf9-4ce2-acc9-2ea9698eb5c4" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_2d0ca1ff-3389-4271-9921-2252842e8ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c4506f58-5786-4753-8721-06586caf4ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a31e9d21-ebf9-4ce2-acc9-2ea9698eb5c4" xlink:to="loc_us-gaap_ShareBasedCompensation_c4506f58-5786-4753-8721-06586caf4ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_111f8d12-e9e5-4fe6-aeb2-f0db64195f65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a31e9d21-ebf9-4ce2-acc9-2ea9698eb5c4" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_111f8d12-e9e5-4fe6-aeb2-f0db64195f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_b2b032c4-10a7-46dd-86eb-71f934783730" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_111f8d12-e9e5-4fe6-aeb2-f0db64195f65" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_b2b032c4-10a7-46dd-86eb-71f934783730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_83aeeef0-1f15-4ec5-aadc-cd2d973f1925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_111f8d12-e9e5-4fe6-aeb2-f0db64195f65" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_83aeeef0-1f15-4ec5-aadc-cd2d973f1925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_0e67f464-e4a5-4050-add2-16b82ecb393e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_111f8d12-e9e5-4fe6-aeb2-f0db64195f65" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_0e67f464-e4a5-4050-add2-16b82ecb393e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_IncreaseDecreaseInAccruedResearchAndDevelopment_f8c91b1b-1bf4-44b2-96b0-fd66ca834483" xlink:href="isee-20220630.xsd#isee_IncreaseDecreaseInAccruedResearchAndDevelopment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_111f8d12-e9e5-4fe6-aeb2-f0db64195f65" xlink:to="loc_isee_IncreaseDecreaseInAccruedResearchAndDevelopment_f8c91b1b-1bf4-44b2-96b0-fd66ca834483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_773d1a56-c068-420e-9c1b-512d52fd92b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_111f8d12-e9e5-4fe6-aeb2-f0db64195f65" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_773d1a56-c068-420e-9c1b-512d52fd92b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_IncreaseDecreaseInWorkingCapital_3af97420-c1eb-4418-8fd1-4d739aef4a98" xlink:href="isee-20220630.xsd#isee_IncreaseDecreaseInWorkingCapital"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_111f8d12-e9e5-4fe6-aeb2-f0db64195f65" xlink:to="loc_isee_IncreaseDecreaseInWorkingCapital_3af97420-c1eb-4418-8fd1-4d739aef4a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_067c8560-7251-46db-88b5-b02892b90f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_dbb8cd81-1e18-48ae-8a5a-12ce043c70ff" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_067c8560-7251-46db-88b5-b02892b90f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_47afa886-e0a5-45c5-bddf-4a0717628eab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5dcc6aa4-5d33-4a84-a61b-ca1877ef05e8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_47afa886-e0a5-45c5-bddf-4a0717628eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_408cbd00-f14e-4d4f-87d3-4e884cf9cc47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_47afa886-e0a5-45c5-bddf-4a0717628eab" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_408cbd00-f14e-4d4f-87d3-4e884cf9cc47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3f87b901-e91e-459d-931e-0b357e7b34f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_47afa886-e0a5-45c5-bddf-4a0717628eab" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3f87b901-e91e-459d-931e-0b357e7b34f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_78eeb053-309e-4750-9e7b-b968fb1d8a61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_47afa886-e0a5-45c5-bddf-4a0717628eab" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_78eeb053-309e-4750-9e7b-b968fb1d8a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1bcc0238-61bc-4edf-9ce2-6a32dff75194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_47afa886-e0a5-45c5-bddf-4a0717628eab" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1bcc0238-61bc-4edf-9ce2-6a32dff75194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_e449018b-2fa1-4fb9-98c5-8200236af9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5dcc6aa4-5d33-4a84-a61b-ca1877ef05e8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_e449018b-2fa1-4fb9-98c5-8200236af9dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ProceedsFromStockOptionsAndWarrantsExercised_192cf8f2-113b-4014-b4f8-2164be7ce68b" xlink:href="isee-20220630.xsd#isee_ProceedsFromStockOptionsAndWarrantsExercised"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_e449018b-2fa1-4fb9-98c5-8200236af9dd" xlink:to="loc_isee_ProceedsFromStockOptionsAndWarrantsExercised_192cf8f2-113b-4014-b4f8-2164be7ce68b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_54c0f135-b2e9-41f2-b4ec-1b1be08fd4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_e449018b-2fa1-4fb9-98c5-8200236af9dd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_54c0f135-b2e9-41f2-b4ec-1b1be08fd4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_810c6843-db52-4b63-9fb3-aee98d72e405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5dcc6aa4-5d33-4a84-a61b-ca1877ef05e8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_810c6843-db52-4b63-9fb3-aee98d72e405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_8c409a74-f263-45f4-bc7e-1a29ae1e0195" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5dcc6aa4-5d33-4a84-a61b-ca1877ef05e8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_8c409a74-f263-45f4-bc7e-1a29ae1e0195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_136b1638-4e8b-4fa4-984e-049cfdb1aeb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_8c409a74-f263-45f4-bc7e-1a29ae1e0195" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_136b1638-4e8b-4fa4-984e-049cfdb1aeb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1e8cf883-8d22-4b5a-92dc-5a076a8df8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_8c409a74-f263-45f4-bc7e-1a29ae1e0195" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1e8cf883-8d22-4b5a-92dc-5a076a8df8ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_14712a55-1d3e-4917-986c-2904bc6f7c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5dcc6aa4-5d33-4a84-a61b-ca1877ef05e8" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_14712a55-1d3e-4917-986c-2904bc6f7c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIncomeTaxRefunds_3d63bcdc-4eba-4c28-90df-62d7dc29a3c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIncomeTaxRefunds"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_14712a55-1d3e-4917-986c-2904bc6f7c13" xlink:to="loc_us-gaap_ProceedsFromIncomeTaxRefunds_3d63bcdc-4eba-4c28-90df-62d7dc29a3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8401b715-af6e-446b-b069-63a0bf892ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5dcc6aa4-5d33-4a84-a61b-ca1877ef05e8" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8401b715-af6e-446b-b069-63a0bf892ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_8cd6c38d-674e-42db-8208-6e698eb1ac7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8401b715-af6e-446b-b069-63a0bf892ef8" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_8cd6c38d-674e-42db-8208-6e698eb1ac7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/Business" xlink:type="simple" xlink:href="isee-20220630.xsd#Business"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/Business" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d527cf2-4df3-4da9-93a5-33a82dfa1c11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_abe19f78-fe7f-44c3-b848-b84dbb75c530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d527cf2-4df3-4da9-93a5-33a82dfa1c11" xlink:to="loc_us-gaap_NatureOfOperations_abe19f78-fe7f-44c3-b848-b84dbb75c530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/BusinessDetails" xlink:type="simple" xlink:href="isee-20220630.xsd#BusinessDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/BusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03fff76e-bd3a-42ab-83ce-d0bda0426cde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_e25cdb30-3fcc-4010-b72c-cf05d4c591a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03fff76e-bd3a-42ab-83ce-d0bda0426cde" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_e25cdb30-3fcc-4010-b72c-cf05d4c591a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_674ca468-9f84-4cb3-be21-b479f7ecbd21" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_e25cdb30-3fcc-4010-b72c-cf05d4c591a5" xlink:to="loc_srt_ProductOrServiceAxis_674ca468-9f84-4cb3-be21-b479f7ecbd21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6d1fe887-2a10-40a6-b1fd-2260c2f08578" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_674ca468-9f84-4cb3-be21-b479f7ecbd21" xlink:to="loc_srt_ProductsAndServicesDomain_6d1fe887-2a10-40a6-b1fd-2260c2f08578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AdenoAssociatedVirusMediatedGeneTherapyProgramMember_eed3d828-f4f7-4640-b0e1-03067e7c69e8" xlink:href="isee-20220630.xsd#isee_AdenoAssociatedVirusMediatedGeneTherapyProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6d1fe887-2a10-40a6-b1fd-2260c2f08578" xlink:to="loc_isee_AdenoAssociatedVirusMediatedGeneTherapyProgramMember_eed3d828-f4f7-4640-b0e1-03067e7c69e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4809649e-c3eb-4e53-8dcf-bff421b66aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_e25cdb30-3fcc-4010-b72c-cf05d4c591a5" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4809649e-c3eb-4e53-8dcf-bff421b66aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_NumberOfProductCandidatesInPreclinicalDevelopment_0db98709-1953-4c3b-bf5f-4bd65394948e" xlink:href="isee-20220630.xsd#isee_NumberOfProductCandidatesInPreclinicalDevelopment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4809649e-c3eb-4e53-8dcf-bff421b66aa5" xlink:to="loc_isee_NumberOfProductCandidatesInPreclinicalDevelopment_0db98709-1953-4c3b-bf5f-4bd65394948e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="isee-20220630.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_78eb8600-a00e-48ff-9218-f4c49f17c599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_65258204-7efe-40b1-a029-749a009b074e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_78eb8600-a00e-48ff-9218-f4c49f17c599" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_65258204-7efe-40b1-a029-749a009b074e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="isee-20220630.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_10854f94-9e09-4c22-b39a-104a44e52c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_32d2bfd7-7513-44a7-a10d-5d1a2e75fb5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_10854f94-9e09-4c22-b39a-104a44e52c6f" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_32d2bfd7-7513-44a7-a10d-5d1a2e75fb5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_7bfd50a0-8633-430e-aa16-2e450f7e7cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_10854f94-9e09-4c22-b39a-104a44e52c6f" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_7bfd50a0-8633-430e-aa16-2e450f7e7cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_9e3b8705-2c9a-4a25-9a99-e880868d682f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_10854f94-9e09-4c22-b39a-104a44e52c6f" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_9e3b8705-2c9a-4a25-9a99-e880868d682f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_a16d36b0-a097-438e-8bc2-8368d01f3cee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_10854f94-9e09-4c22-b39a-104a44e52c6f" xlink:to="loc_us-gaap_UseOfEstimates_a16d36b0-a097-438e-8bc2-8368d01f3cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_9b7f79c5-8a3f-4987-9229-bbbd648ecf6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_10854f94-9e09-4c22-b39a-104a44e52c6f" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_9b7f79c5-8a3f-4987-9229-bbbd648ecf6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_c0ca0105-6996-41f2-af74-e2cc3ff13d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditLossFinancialInstrumentPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_10854f94-9e09-4c22-b39a-104a44e52c6f" xlink:to="loc_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_c0ca0105-6996-41f2-af74-e2cc3ff13d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_1756d2dc-8f8c-452d-af26-90bd3ac0140d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_10854f94-9e09-4c22-b39a-104a44e52c6f" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_1756d2dc-8f8c-452d-af26-90bd3ac0140d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_aebb2fb8-7b78-4885-8605-3f0e370e4692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_10854f94-9e09-4c22-b39a-104a44e52c6f" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_aebb2fb8-7b78-4885-8605-3f0e370e4692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ConcentrationOfSuppliersPolicyPolicyTextBlock_4d9ac84b-3df3-492e-8377-2a77e6325510" xlink:href="isee-20220630.xsd#isee_ConcentrationOfSuppliersPolicyPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_10854f94-9e09-4c22-b39a-104a44e52c6f" xlink:to="loc_isee_ConcentrationOfSuppliersPolicyPolicyTextBlock_4d9ac84b-3df3-492e-8377-2a77e6325510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_b6a16967-29dd-47c7-a48d-18ddede54364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_10854f94-9e09-4c22-b39a-104a44e52c6f" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_b6a16967-29dd-47c7-a48d-18ddede54364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_a9a41dd2-ab90-4d1d-bff8-e172a6ed3c20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_10854f94-9e09-4c22-b39a-104a44e52c6f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_a9a41dd2-ab90-4d1d-bff8-e172a6ed3c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_74f139f4-6319-44d6-90d6-8fb3aaced639" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_10854f94-9e09-4c22-b39a-104a44e52c6f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_74f139f4-6319-44d6-90d6-8fb3aaced639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_d0945276-8161-460e-a183-1ec9baa39860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_10854f94-9e09-4c22-b39a-104a44e52c6f" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_d0945276-8161-460e-a183-1ec9baa39860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_671b5ac4-d07b-4256-8bb2-fcbabb85ac63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_10854f94-9e09-4c22-b39a-104a44e52c6f" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_671b5ac4-d07b-4256-8bb2-fcbabb85ac63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9ce39d9b-fe12-43d8-b490-0b763b197f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_10854f94-9e09-4c22-b39a-104a44e52c6f" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9ce39d9b-fe12-43d8-b490-0b763b197f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="isee-20220630.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3e274365-c5e8-4c54-8447-4e9cb5bcd156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_fd188d0a-8162-4f90-9d65-618c9f6214b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3e274365-c5e8-4c54-8447-4e9cb5bcd156" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_fd188d0a-8162-4f90-9d65-618c9f6214b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesSegmentandGeographicInformationDetails" xlink:type="simple" xlink:href="isee-20220630.xsd#SummaryofSignificantAccountingPoliciesSegmentandGeographicInformationDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesSegmentandGeographicInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c1045c77-fb8b-41b4-b608-b7c7fa8a9c32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_c0080f05-4646-4f55-8b12-cdde79aec600" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c1045c77-fb8b-41b4-b608-b7c7fa8a9c32" xlink:to="loc_us-gaap_NumberOfOperatingSegments_c0080f05-4646-4f55-8b12-cdde79aec600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_9674f36f-acf7-4868-8748-1a6f98333602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c1045c77-fb8b-41b4-b608-b7c7fa8a9c32" xlink:to="loc_us-gaap_NumberOfReportableSegments_9674f36f-acf7-4868-8748-1a6f98333602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="simple" xlink:href="isee-20220630.xsd#SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b07d6b46-e9de-466f-b4d6-0c7cb3ccd996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7bd14a73-e218-48e4-87b5-a6b8fd85ad86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b07d6b46-e9de-466f-b4d6-0c7cb3ccd996" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7bd14a73-e218-48e4-87b5-a6b8fd85ad86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0961f662-bc07-4707-93cd-4f8e1827a052" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7bd14a73-e218-48e4-87b5-a6b8fd85ad86" xlink:to="loc_srt_RangeAxis_0961f662-bc07-4707-93cd-4f8e1827a052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1d183c11-d3be-49b5-bb69-4954e94fed86" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0961f662-bc07-4707-93cd-4f8e1827a052" xlink:to="loc_srt_RangeMember_1d183c11-d3be-49b5-bb69-4954e94fed86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_97851921-6641-4bda-a653-fc3666b4ce16" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1d183c11-d3be-49b5-bb69-4954e94fed86" xlink:to="loc_srt_MinimumMember_97851921-6641-4bda-a653-fc3666b4ce16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1200176f-2297-4823-9487-3043197dbe29" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1d183c11-d3be-49b5-bb69-4954e94fed86" xlink:to="loc_srt_MaximumMember_1200176f-2297-4823-9487-3043197dbe29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1ac51291-eef3-4ab2-86a9-3ea8a281a9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7bd14a73-e218-48e4-87b5-a6b8fd85ad86" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1ac51291-eef3-4ab2-86a9-3ea8a281a9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_bf0550de-7c22-42f7-b404-40e097ec7be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1ac51291-eef3-4ab2-86a9-3ea8a281a9d7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_bf0550de-7c22-42f7-b404-40e097ec7be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesShareBasedCompensationDetails" xlink:type="simple" xlink:href="isee-20220630.xsd#SummaryofSignificantAccountingPoliciesShareBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesShareBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f1160857-e2f4-4f05-aaf4-a8854778b7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_ba9b77b7-4f23-4818-91e0-2b2a68a0bd83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f1160857-e2f4-4f05-aaf4-a8854778b7ec" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_ba9b77b7-4f23-4818-91e0-2b2a68a0bd83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_291528f1-7e39-4640-9d4e-23534779f5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_ba9b77b7-4f23-4818-91e0-2b2a68a0bd83" xlink:to="loc_us-gaap_AwardTypeAxis_291528f1-7e39-4640-9d4e-23534779f5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c30f124c-4f0c-4900-9b26-dbdaddb1bbfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_291528f1-7e39-4640-9d4e-23534779f5a3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c30f124c-4f0c-4900-9b26-dbdaddb1bbfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_8376a46e-2ea3-4d34-bed4-838fc4f27ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c30f124c-4f0c-4900-9b26-dbdaddb1bbfa" xlink:to="loc_us-gaap_EmployeeStockMember_8376a46e-2ea3-4d34-bed4-838fc4f27ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_34f4520e-a0d6-473e-ba04-c81b78084eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_ba9b77b7-4f23-4818-91e0-2b2a68a0bd83" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_34f4520e-a0d6-473e-ba04-c81b78084eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_864f2fcc-e8a8-4978-bc51-7c082e17e78e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_34f4520e-a0d6-473e-ba04-c81b78084eb2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_864f2fcc-e8a8-4978-bc51-7c082e17e78e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0d57c937-85e0-4a3b-a369-8252ce5ae9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_34f4520e-a0d6-473e-ba04-c81b78084eb2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0d57c937-85e0-4a3b-a369-8252ce5ae9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_8590defd-ac8c-4f7a-8622-dee552a83e9b" xlink:href="isee-20220630.xsd#isee_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_34f4520e-a0d6-473e-ba04-c81b78084eb2" xlink:to="loc_isee_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_8590defd-ac8c-4f7a-8622-dee552a83e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofWeightedAverageAssumptionsDetails" xlink:type="simple" xlink:href="isee-20220630.xsd#SummaryofSignificantAccountingPoliciesScheduleofWeightedAverageAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofWeightedAverageAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8e13a94d-baea-4e23-9a7a-cad18a3450c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_415b04c4-0afb-4f3b-9edb-274f3cb4714b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8e13a94d-baea-4e23-9a7a-cad18a3450c6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_415b04c4-0afb-4f3b-9edb-274f3cb4714b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_cc56a43e-0eef-4511-bd61-fc39ab1afd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_415b04c4-0afb-4f3b-9edb-274f3cb4714b" xlink:to="loc_us-gaap_AwardTypeAxis_cc56a43e-0eef-4511-bd61-fc39ab1afd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aff0b70a-a8f4-4684-aeae-1325d175b4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_cc56a43e-0eef-4511-bd61-fc39ab1afd2f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aff0b70a-a8f4-4684-aeae-1325d175b4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_c81602c4-3bd9-4b57-95da-bbbcc87bd43c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aff0b70a-a8f4-4684-aeae-1325d175b4c7" xlink:to="loc_us-gaap_EmployeeStockOptionMember_c81602c4-3bd9-4b57-95da-bbbcc87bd43c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_082b00d3-4d77-4063-b97a-870803796a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_415b04c4-0afb-4f3b-9edb-274f3cb4714b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_082b00d3-4d77-4063-b97a-870803796a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_60496497-cb3f-4a8f-acd1-6534095582e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_082b00d3-4d77-4063-b97a-870803796a6b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_60496497-cb3f-4a8f-acd1-6534095582e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_41da05cd-98ae-485f-9400-2bd7419f8587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_082b00d3-4d77-4063-b97a-870803796a6b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_41da05cd-98ae-485f-9400-2bd7419f8587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_095345f9-8c90-4fd0-8290-c627c59e2166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_082b00d3-4d77-4063-b97a-870803796a6b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_095345f9-8c90-4fd0-8290-c627c59e2166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_56abb0ad-ebfd-461d-bde7-5800f9b04d37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_082b00d3-4d77-4063-b97a-870803796a6b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_56abb0ad-ebfd-461d-bde7-5800f9b04d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_594d7378-ad16-4e1f-8371-8a35b8d0e468" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_082b00d3-4d77-4063-b97a-870803796a6b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_594d7378-ad16-4e1f-8371-8a35b8d0e468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/NetLossPerCommonShare" xlink:type="simple" xlink:href="isee-20220630.xsd#NetLossPerCommonShare"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/NetLossPerCommonShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ebcf85d4-b863-49f6-b960-5e5ba8b0ba10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_63c9f515-46a9-46f6-9bf7-8f668e10736e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ebcf85d4-b863-49f6-b960-5e5ba8b0ba10" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_63c9f515-46a9-46f6-9bf7-8f668e10736e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/NetLossPerCommonShareTables" xlink:type="simple" xlink:href="isee-20220630.xsd#NetLossPerCommonShareTables"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/NetLossPerCommonShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_31135260-ed9e-43ea-b8ab-a9af52eca419" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_cce30ae8-41f1-485c-842c-88dc173a9d47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_31135260-ed9e-43ea-b8ab-a9af52eca419" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_cce30ae8-41f1-485c-842c-88dc173a9d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_3f131008-7c1a-4b31-b797-7953cb817837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_31135260-ed9e-43ea-b8ab-a9af52eca419" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_3f131008-7c1a-4b31-b797-7953cb817837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/NetLossPerCommonShareNarrativeDetails" xlink:type="simple" xlink:href="isee-20220630.xsd#NetLossPerCommonShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/NetLossPerCommonShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1402a27f-34a1-46ae-9885-316a6d084d25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_2c7b10a1-374a-46bd-ae43-2ec452b315e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1402a27f-34a1-46ae-9885-316a6d084d25" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_2c7b10a1-374a-46bd-ae43-2ec452b315e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/NetLossPerCommonShareSchedulesofNetLossPerShareandDilutiveSecuritiesDetails" xlink:type="simple" xlink:href="isee-20220630.xsd#NetLossPerCommonShareSchedulesofNetLossPerShareandDilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/NetLossPerCommonShareSchedulesofNetLossPerShareandDilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9491bb34-eca0-42bf-9a61-d82c280b029c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract_a8da9db6-5969-4c73-8511-0eb1d7767f22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9491bb34-eca0-42bf-9a61-d82c280b029c" xlink:to="loc_us-gaap_NetIncomeLossAbstract_a8da9db6-5969-4c73-8511-0eb1d7767f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_406e0792-f1f4-4251-9d07-b9d6cf1d4f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_a8da9db6-5969-4c73-8511-0eb1d7767f22" xlink:to="loc_us-gaap_NetIncomeLoss_406e0792-f1f4-4251-9d07-b9d6cf1d4f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_041b07b9-8558-4aa0-93ea-cc9211f3936b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_a8da9db6-5969-4c73-8511-0eb1d7767f22" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_041b07b9-8558-4aa0-93ea-cc9211f3936b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f8bd0d56-c4c7-4a36-9ac1-260e59fff9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_a8da9db6-5969-4c73-8511-0eb1d7767f22" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f8bd0d56-c4c7-4a36-9ac1-260e59fff9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_018d872c-89be-44f5-a035-7ea4ee60980f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_a8da9db6-5969-4c73-8511-0eb1d7767f22" xlink:to="loc_us-gaap_EarningsPerShareBasic_018d872c-89be-44f5-a035-7ea4ee60980f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_9b540908-8661-4162-a7c8-3ef1a3a09176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_a8da9db6-5969-4c73-8511-0eb1d7767f22" xlink:to="loc_us-gaap_EarningsPerShareDiluted_9b540908-8661-4162-a7c8-3ef1a3a09176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/NetLossPerCommonSharePotentiallyDilutiveSecuritiesDetails" xlink:type="simple" xlink:href="isee-20220630.xsd#NetLossPerCommonSharePotentiallyDilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/NetLossPerCommonSharePotentiallyDilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9391d397-23d6-43fc-a501-032be65d9a00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c23da3c3-ff81-4851-8437-d523a0ca988c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9391d397-23d6-43fc-a501-032be65d9a00" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c23da3c3-ff81-4851-8437-d523a0ca988c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f7c94356-e33c-436b-ba55-4aa02fb7657f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c23da3c3-ff81-4851-8437-d523a0ca988c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f7c94356-e33c-436b-ba55-4aa02fb7657f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_66485711-5466-4a21-b6e1-df65998a3e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f7c94356-e33c-436b-ba55-4aa02fb7657f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_66485711-5466-4a21-b6e1-df65998a3e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_EmployeeAndNonemployeeStockOptionMember_efd0d5cd-1e21-4769-adf3-bd513a8dbb62" xlink:href="isee-20220630.xsd#isee_EmployeeAndNonemployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_66485711-5466-4a21-b6e1-df65998a3e6c" xlink:to="loc_isee_EmployeeAndNonemployeeStockOptionMember_efd0d5cd-1e21-4769-adf3-bd513a8dbb62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_42b79721-7e84-4d40-b4ea-fdeed3c5122f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_66485711-5466-4a21-b6e1-df65998a3e6c" xlink:to="loc_us-gaap_RestrictedStockMember_42b79721-7e84-4d40-b4ea-fdeed3c5122f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_fbbae75f-5dab-46ae-aace-55c77b162f44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c23da3c3-ff81-4851-8437-d523a0ca988c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_fbbae75f-5dab-46ae-aace-55c77b162f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1ffda9f7-247e-4075-bb2f-dd31585772bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_fbbae75f-5dab-46ae-aace-55c77b162f44" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1ffda9f7-247e-4075-bb2f-dd31585772bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/LicensingandCommercializationAgreements" xlink:type="simple" xlink:href="isee-20220630.xsd#LicensingandCommercializationAgreements"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/LicensingandCommercializationAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_63413132-e338-4762-aaa1-6a292e2dc196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_9dde3a69-6856-4cca-b2ce-78d994648642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_63413132-e338-4762-aaa1-6a292e2dc196" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_9dde3a69-6856-4cca-b2ce-78d994648642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/LicensingandCommercializationAgreementsDetails" xlink:type="simple" xlink:href="isee-20220630.xsd#LicensingandCommercializationAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/LicensingandCommercializationAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_785b3ff2-a9c4-4442-8dcd-a9557de1f5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_69e86153-b60e-4e1f-9192-e719353e44e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_785b3ff2-a9c4-4442-8dcd-a9557de1f5e9" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_69e86153-b60e-4e1f-9192-e719353e44e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_208feb6a-228a-44d2-a6f9-2c47c8968666" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_69e86153-b60e-4e1f-9192-e719353e44e3" xlink:to="loc_srt_CounterpartyNameAxis_208feb6a-228a-44d2-a6f9-2c47c8968666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fc7ed476-eb2e-427f-b71c-b620687143fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_208feb6a-228a-44d2-a6f9-2c47c8968666" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fc7ed476-eb2e-427f-b71c-b620687143fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_DelSiTechMember_aac4be05-82c8-499e-b569-0666b989128f" xlink:href="isee-20220630.xsd#isee_DelSiTechMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fc7ed476-eb2e-427f-b71c-b620687143fe" xlink:to="loc_isee_DelSiTechMember_aac4be05-82c8-499e-b569-0666b989128f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_27203bb2-a732-4ab8-9426-9070076ae8c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_69e86153-b60e-4e1f-9192-e719353e44e3" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_27203bb2-a732-4ab8-9426-9070076ae8c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c00d0ae4-5dbf-4601-8113-e9178f869c40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_27203bb2-a732-4ab8-9426-9070076ae8c3" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c00d0ae4-5dbf-4601-8113-e9178f869c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAgreementTermsMember_9c451325-f9e5-44a2-94cd-3232b6113676" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAgreementTermsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c00d0ae4-5dbf-4601-8113-e9178f869c40" xlink:to="loc_us-gaap_LicenseAgreementTermsMember_9c451325-f9e5-44a2-94cd-3232b6113676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1788c60b-4e47-4306-9908-70f83df5daf1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_69e86153-b60e-4e1f-9192-e719353e44e3" xlink:to="loc_srt_ProductOrServiceAxis_1788c60b-4e47-4306-9908-70f83df5daf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_95a6222c-6a0b-4c1d-9ed0-54f89b861d73" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_1788c60b-4e47-4306-9908-70f83df5daf1" xlink:to="loc_srt_ProductsAndServicesDomain_95a6222c-6a0b-4c1d-9ed0-54f89b861d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ZimuraMember_2ec6719d-218c-4162-897d-32f1bfa044e6" xlink:href="isee-20220630.xsd#isee_ZimuraMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_95a6222c-6a0b-4c1d-9ed0-54f89b861d73" xlink:to="loc_isee_ZimuraMember_2ec6719d-218c-4162-897d-32f1bfa044e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MilestoneEventsAxis_6414faff-0a48-4fb7-aed2-6137cb064c97" xlink:href="isee-20220630.xsd#isee_MilestoneEventsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_69e86153-b60e-4e1f-9192-e719353e44e3" xlink:to="loc_isee_MilestoneEventsAxis_6414faff-0a48-4fb7-aed2-6137cb064c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MilestoneEventsDomain_6143ef5b-e109-43f5-bcc0-8b6157ec1e11" xlink:href="isee-20220630.xsd#isee_MilestoneEventsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsAxis_6414faff-0a48-4fb7-aed2-6137cb064c97" xlink:to="loc_isee_MilestoneEventsDomain_6143ef5b-e109-43f5-bcc0-8b6157ec1e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AchievementOfSpecifiedClinicalAndDevelopmentMilestonesMember_b5cdb211-5a6c-4b9c-954b-5b918ee39535" xlink:href="isee-20220630.xsd#isee_AchievementOfSpecifiedClinicalAndDevelopmentMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_6143ef5b-e109-43f5-bcc0-8b6157ec1e11" xlink:to="loc_isee_AchievementOfSpecifiedClinicalAndDevelopmentMilestonesMember_b5cdb211-5a6c-4b9c-954b-5b918ee39535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AchievementOfSpecifiedCommercialSalesMilestonesMember_b3f22033-c8c2-4758-bfdc-0d22b8313e1b" xlink:href="isee-20220630.xsd#isee_AchievementOfSpecifiedCommercialSalesMilestonesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_6143ef5b-e109-43f5-bcc0-8b6157ec1e11" xlink:to="loc_isee_AchievementOfSpecifiedCommercialSalesMilestonesMember_b3f22033-c8c2-4758-bfdc-0d22b8313e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d7dfd463-4152-461f-80df-bc2abe0a5d40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_69e86153-b60e-4e1f-9192-e719353e44e3" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d7dfd463-4152-461f-80df-bc2abe0a5d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_LicenseAgreementPaymentDuePeriod_4ce50775-0613-4d86-bd5a-004067f6610a" xlink:href="isee-20220630.xsd#isee_LicenseAgreementPaymentDuePeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d7dfd463-4152-461f-80df-bc2abe0a5d40" xlink:to="loc_isee_LicenseAgreementPaymentDuePeriod_4ce50775-0613-4d86-bd5a-004067f6610a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_PaymentsForLicenseFees_4e2820e1-ea9d-4a3d-acbe-63a21dd2d51c" xlink:href="isee-20220630.xsd#isee_PaymentsForLicenseFees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d7dfd463-4152-461f-80df-bc2abe0a5d40" xlink:to="loc_isee_PaymentsForLicenseFees_4e2820e1-ea9d-4a3d-acbe-63a21dd2d51c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AmountToBePaidOnAchievementOfMilestone_b32e92e0-9fa0-416c-9dd3-3fd99de8e896" xlink:href="isee-20220630.xsd#isee_AmountToBePaidOnAchievementOfMilestone"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d7dfd463-4152-461f-80df-bc2abe0a5d40" xlink:to="loc_isee_AmountToBePaidOnAchievementOfMilestone_b32e92e0-9fa0-416c-9dd3-3fd99de8e896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_LicenseAgreementTerminationNoticePeriod_925cbce7-a1cf-4160-89e2-32d1e9c06d8b" xlink:href="isee-20220630.xsd#isee_LicenseAgreementTerminationNoticePeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d7dfd463-4152-461f-80df-bc2abe0a5d40" xlink:to="loc_isee_LicenseAgreementTerminationNoticePeriod_925cbce7-a1cf-4160-89e2-32d1e9c06d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CashCashEquivalentsandAvailableforSaleSecurities" xlink:type="simple" xlink:href="isee-20220630.xsd#CashCashEquivalentsandAvailableforSaleSecurities"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CashCashEquivalentsandAvailableforSaleSecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract_7702ef65-da39-4a13-83d0-72876e521e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock_5bb961ef-b8bc-4b60-807b-c2b819bfce20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract_7702ef65-da39-4a13-83d0-72876e521e2b" xlink:to="loc_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock_5bb961ef-b8bc-4b60-807b-c2b819bfce20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CashCashEquivalentsandAvailableforSaleSecuritiesTables" xlink:type="simple" xlink:href="isee-20220630.xsd#CashCashEquivalentsandAvailableforSaleSecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CashCashEquivalentsandAvailableforSaleSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract_7b08ebbf-87df-4b0c-984e-414b57dcd096" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_67c0123e-64ed-4bbf-bed0-240ef2fe1b57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract_7b08ebbf-87df-4b0c-984e-414b57dcd096" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_67c0123e-64ed-4bbf-bed0-240ef2fe1b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_bb01eade-f804-4aa5-a34c-0fa0f7098bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract_7b08ebbf-87df-4b0c-984e-414b57dcd096" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_bb01eade-f804-4aa5-a34c-0fa0f7098bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CashCashEquivalentsandAvailableforSaleSecuritiesNarrativeDetails" xlink:type="simple" xlink:href="isee-20220630.xsd#CashCashEquivalentsandAvailableforSaleSecuritiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CashCashEquivalentsandAvailableforSaleSecuritiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract_047ee5c6-8cc3-4d17-8024-725207f1a85b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_75fd8f3c-2e23-4bf6-98f9-109d4a65b0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract_047ee5c6-8cc3-4d17-8024-725207f1a85b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_75fd8f3c-2e23-4bf6-98f9-109d4a65b0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_aeb1851a-2037-4c61-9f21-09a0ea70df2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract_047ee5c6-8cc3-4d17-8024-725207f1a85b" xlink:to="loc_us-gaap_Cash_aeb1851a-2037-4c61-9f21-09a0ea70df2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_b3ae5a8f-7c05-4913-9270-2d5d511d8131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract_047ee5c6-8cc3-4d17-8024-725207f1a85b" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_b3ae5a8f-7c05-4913-9270-2d5d511d8131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_af58c857-f813-4736-b465-0c758da3e2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract_047ee5c6-8cc3-4d17-8024-725207f1a85b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_af58c857-f813-4736-b465-0c758da3e2a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CashCashEquivalentsandAvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesDetails" xlink:type="simple" xlink:href="isee-20220630.xsd#CashCashEquivalentsandAvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CashCashEquivalentsandAvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract_7b2a8998-1ec9-411f-9d8b-cad7f12c9e59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a192a020-0607-4db1-a87a-28d0e2e93c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract_7b2a8998-1ec9-411f-9d8b-cad7f12c9e59" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a192a020-0607-4db1-a87a-28d0e2e93c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_620e5d65-fe1e-4c62-9cf9-848b64d2832c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a192a020-0607-4db1-a87a-28d0e2e93c3e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_620e5d65-fe1e-4c62-9cf9-848b64d2832c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6adfc40a-8202-4219-8f95-19fbe48e3cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_620e5d65-fe1e-4c62-9cf9-848b64d2832c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6adfc40a-8202-4219-8f95-19fbe48e3cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_120681a3-a01e-4d96-b6b4-ae31a07fa94f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6adfc40a-8202-4219-8f95-19fbe48e3cd6" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_120681a3-a01e-4d96-b6b4-ae31a07fa94f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_27596255-122d-4c6a-9cff-73bb03108943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6adfc40a-8202-4219-8f95-19fbe48e3cd6" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_27596255-122d-4c6a-9cff-73bb03108943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_7b7afc41-9012-4831-9845-7e72268b45be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6adfc40a-8202-4219-8f95-19fbe48e3cd6" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_7b7afc41-9012-4831-9845-7e72268b45be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SupranationalSecuritiesMember_85ec44b0-fe6f-47b2-9b9c-0b71b7649744" xlink:href="isee-20220630.xsd#isee_SupranationalSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6adfc40a-8202-4219-8f95-19fbe48e3cd6" xlink:to="loc_isee_SupranationalSecuritiesMember_85ec44b0-fe6f-47b2-9b9c-0b71b7649744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0ef57cc2-fb78-4c39-bb15-ae007423b616" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a192a020-0607-4db1-a87a-28d0e2e93c3e" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0ef57cc2-fb78-4c39-bb15-ae007423b616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_557359e2-35e9-4ea3-9dca-8b704fd5ad98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0ef57cc2-fb78-4c39-bb15-ae007423b616" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_557359e2-35e9-4ea3-9dca-8b704fd5ad98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_171655a9-a216-4452-b466-eee617574254" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0ef57cc2-fb78-4c39-bb15-ae007423b616" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_171655a9-a216-4452-b466-eee617574254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_96eba7df-83dd-4e2a-9610-a6121eba1a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0ef57cc2-fb78-4c39-bb15-ae007423b616" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_96eba7df-83dd-4e2a-9610-a6121eba1a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_60c263a8-6c3a-4ae0-ab88-693644825ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0ef57cc2-fb78-4c39-bb15-ae007423b616" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_60c263a8-6c3a-4ae0-ab88-693644825ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CashCashEquivalentsandAvailableforSaleSecuritiesScheduleofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="isee-20220630.xsd#CashCashEquivalentsandAvailableforSaleSecuritiesScheduleofAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CashCashEquivalentsandAvailableforSaleSecuritiesScheduleofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract_5c5acb5b-2c9d-40d5-a2ba-3a0ea49579c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_39ce4bda-1e3d-4cba-80b0-99df94150be5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract_5c5acb5b-2c9d-40d5-a2ba-3a0ea49579c8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_39ce4bda-1e3d-4cba-80b0-99df94150be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_014cc3f0-339b-4758-a3e2-af8ddd7bf8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_39ce4bda-1e3d-4cba-80b0-99df94150be5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_014cc3f0-339b-4758-a3e2-af8ddd7bf8b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_73919b9e-e6b3-49e3-b7e6-1bc1dfb923a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_014cc3f0-339b-4758-a3e2-af8ddd7bf8b1" xlink:to="loc_us-gaap_EquityComponentDomain_73919b9e-e6b3-49e3-b7e6-1bc1dfb923a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_4262704e-5aa6-43e1-ba64-96cfaf7e70d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_73919b9e-e6b3-49e3-b7e6-1bc1dfb923a6" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_4262704e-5aa6-43e1-ba64-96cfaf7e70d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_30312655-01bf-47fc-a3d2-95b015601105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_39ce4bda-1e3d-4cba-80b0-99df94150be5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_30312655-01bf-47fc-a3d2-95b015601105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_54fa28c0-083f-4e4b-90e0-82f6fcdcf32a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_30312655-01bf-47fc-a3d2-95b015601105" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_54fa28c0-083f-4e4b-90e0-82f6fcdcf32a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4b31ec97-e297-488b-b179-8ed752ddcfc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_54fa28c0-083f-4e4b-90e0-82f6fcdcf32a" xlink:to="loc_us-gaap_StockholdersEquity_4b31ec97-e297-488b-b179-8ed752ddcfc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_5abad0fc-c2c5-458e-a490-4aa64513477c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_54fa28c0-083f-4e4b-90e0-82f6fcdcf32a" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_5abad0fc-c2c5-458e-a490-4aa64513477c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_9d1bba5d-0fe8-493a-87ff-0be760ff047e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_54fa28c0-083f-4e4b-90e0-82f6fcdcf32a" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_9d1bba5d-0fe8-493a-87ff-0be760ff047e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_828f9c06-8b69-4c61-8b44-73ff569420dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_54fa28c0-083f-4e4b-90e0-82f6fcdcf32a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_828f9c06-8b69-4c61-8b44-73ff569420dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0a2e4b2f-de70-4b0e-b49d-c5c20b54a4fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_54fa28c0-083f-4e4b-90e0-82f6fcdcf32a" xlink:to="loc_us-gaap_StockholdersEquity_0a2e4b2f-de70-4b0e-b49d-c5c20b54a4fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="isee-20220630.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6d54d411-d99f-4c45-b0d9-d5568fa18e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_4901f8cc-b0b6-49ff-8715-f1e47d23fc79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6d54d411-d99f-4c45-b0d9-d5568fa18e0e" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_4901f8cc-b0b6-49ff-8715-f1e47d23fc79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="isee-20220630.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d7a4bc9f-fcbe-40b2-b2a0-ad1798fd71a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_5bbbf41f-ae6a-4865-b519-e9206fd5e4df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d7a4bc9f-fcbe-40b2-b2a0-ad1798fd71a2" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_5bbbf41f-ae6a-4865-b519-e9206fd5e4df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="isee-20220630.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_21fa07f0-7036-4ec3-aa8c-aec9954e3fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_812b68a1-5d16-4079-8959-b2cc303565b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_21fa07f0-7036-4ec3-aa8c-aec9954e3fe4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_812b68a1-5d16-4079-8959-b2cc303565b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0305225f-4d93-453a-98af-8f92026f5191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_812b68a1-5d16-4079-8959-b2cc303565b9" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0305225f-4d93-453a-98af-8f92026f5191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_aa62a092-4d07-4d34-a3ac-7179f4f5ce2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0305225f-4d93-453a-98af-8f92026f5191" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_aa62a092-4d07-4d34-a3ac-7179f4f5ce2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_adc9b89c-dcfd-4d41-8fab-325c3a0c71b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_aa62a092-4d07-4d34-a3ac-7179f4f5ce2a" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_adc9b89c-dcfd-4d41-8fab-325c3a0c71b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_84c0aa8b-2218-4eab-8efb-e84174fd4b21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_812b68a1-5d16-4079-8959-b2cc303565b9" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_84c0aa8b-2218-4eab-8efb-e84174fd4b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_aa565b95-b0f5-467b-8f96-516d9f46e28e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_84c0aa8b-2218-4eab-8efb-e84174fd4b21" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_aa565b95-b0f5-467b-8f96-516d9f46e28e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e68ffcd8-3fdf-49c5-bbd6-d9c3a5b2da59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_aa565b95-b0f5-467b-8f96-516d9f46e28e" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e68ffcd8-3fdf-49c5-bbd6-d9c3a5b2da59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_66346e0b-4c3a-493d-ad7c-9b07bf2e840d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_aa565b95-b0f5-467b-8f96-516d9f46e28e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_66346e0b-4c3a-493d-ad7c-9b07bf2e840d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3be81537-0e8f-4b22-9baa-939e6d425a58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_aa565b95-b0f5-467b-8f96-516d9f46e28e" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3be81537-0e8f-4b22-9baa-939e6d425a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6626f1ee-4b88-4576-8f8c-22287879fcab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_812b68a1-5d16-4079-8959-b2cc303565b9" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6626f1ee-4b88-4576-8f8c-22287879fcab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b8b2376-03dc-476a-8a7d-9f010e981037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6626f1ee-4b88-4576-8f8c-22287879fcab" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b8b2376-03dc-476a-8a7d-9f010e981037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_63879864-7add-4d5b-8190-424bed5c93fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b8b2376-03dc-476a-8a7d-9f010e981037" xlink:to="loc_us-gaap_MoneyMarketFundsMember_63879864-7add-4d5b-8190-424bed5c93fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_26df3c07-971e-4915-bec7-6fdd617fe8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b8b2376-03dc-476a-8a7d-9f010e981037" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_26df3c07-971e-4915-bec7-6fdd617fe8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_b6559a78-1768-4070-a827-c73439effae2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b8b2376-03dc-476a-8a7d-9f010e981037" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_b6559a78-1768-4070-a827-c73439effae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_896ddf52-eb82-4c09-995a-ba4510ddb8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b8b2376-03dc-476a-8a7d-9f010e981037" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_896ddf52-eb82-4c09-995a-ba4510ddb8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SupranationalSecuritiesMember_614c3ab0-ef17-4453-a772-b041c7cc2a67" xlink:href="isee-20220630.xsd#isee_SupranationalSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b8b2376-03dc-476a-8a7d-9f010e981037" xlink:to="loc_isee_SupranationalSecuritiesMember_614c3ab0-ef17-4453-a772-b041c7cc2a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3753f723-16bc-4eb6-886a-385baf2c9623" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_812b68a1-5d16-4079-8959-b2cc303565b9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3753f723-16bc-4eb6-886a-385baf2c9623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_c8b4d12e-8972-4506-808a-1fc777ced90b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3753f723-16bc-4eb6-886a-385baf2c9623" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_c8b4d12e-8972-4506-808a-1fc777ced90b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="isee-20220630.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fd001468-e19c-46bd-970f-303111e367c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_049ad4e7-e19a-48f5-ab0a-341dfe647cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fd001468-e19c-46bd-970f-303111e367c7" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_049ad4e7-e19a-48f5-ab0a-341dfe647cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="isee-20220630.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8eed0207-5ae7-4618-811c-d225d97ae330" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_295a9d4a-cc6e-4c5e-8167-25b855d11901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8eed0207-5ae7-4618-811c-d225d97ae330" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_295a9d4a-cc6e-4c5e-8167-25b855d11901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ScheduleOfCompensationCostForSharebasedPaymentArrangementsAllocationOfSharebasedCompensationCostsByFinancialStatementLineTableTextBlock_7e806fbd-997b-4673-827c-5d86ea495f0c" xlink:href="isee-20220630.xsd#isee_ScheduleOfCompensationCostForSharebasedPaymentArrangementsAllocationOfSharebasedCompensationCostsByFinancialStatementLineTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8eed0207-5ae7-4618-811c-d225d97ae330" xlink:to="loc_isee_ScheduleOfCompensationCostForSharebasedPaymentArrangementsAllocationOfSharebasedCompensationCostsByFinancialStatementLineTableTextBlock_7e806fbd-997b-4673-827c-5d86ea495f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_5f241eb4-5dc2-47a6-98c8-763b6831b779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8eed0207-5ae7-4618-811c-d225d97ae330" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_5f241eb4-5dc2-47a6-98c8-763b6831b779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_24315b30-41fc-4b76-8a7a-091cfa66163b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8eed0207-5ae7-4618-811c-d225d97ae330" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_24315b30-41fc-4b76-8a7a-091cfa66163b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="isee-20220630.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8003e6d5-3362-4678-bee8-a6e51c3894b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_391fd9c3-2901-455a-ab23-ca0ba7691cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8003e6d5-3362-4678-bee8-a6e51c3894b5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_391fd9c3-2901-455a-ab23-ca0ba7691cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_11bac0ef-1c9d-4c0d-b03c-16bb6b392328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_391fd9c3-2901-455a-ab23-ca0ba7691cb9" xlink:to="loc_us-gaap_PlanNameAxis_11bac0ef-1c9d-4c0d-b03c-16bb6b392328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ed278883-d947-4216-a979-4dc0f6541712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_11bac0ef-1c9d-4c0d-b03c-16bb6b392328" xlink:to="loc_us-gaap_PlanNameDomain_ed278883-d947-4216-a979-4dc0f6541712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_StockIncentive2013PlanMember_d226b287-4450-4c4e-a7fa-51093643976d" xlink:href="isee-20220630.xsd#isee_StockIncentive2013PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_ed278883-d947-4216-a979-4dc0f6541712" xlink:to="loc_isee_StockIncentive2013PlanMember_d226b287-4450-4c4e-a7fa-51093643976d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_TwoThousandNineteenInducementPlanMember_ae0c2abe-3c34-4cd5-8591-2f437d99bba5" xlink:href="isee-20220630.xsd#isee_TwoThousandNineteenInducementPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_ed278883-d947-4216-a979-4dc0f6541712" xlink:to="loc_isee_TwoThousandNineteenInducementPlanMember_ae0c2abe-3c34-4cd5-8591-2f437d99bba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_dc87b986-2bad-4f3f-9458-1ffc06f1a9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_391fd9c3-2901-455a-ab23-ca0ba7691cb9" xlink:to="loc_us-gaap_AwardTypeAxis_dc87b986-2bad-4f3f-9458-1ffc06f1a9c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_489252ff-f627-407e-a099-4be8b522853d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_dc87b986-2bad-4f3f-9458-1ffc06f1a9c1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_489252ff-f627-407e-a099-4be8b522853d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_94b026a9-1e16-4b40-a027-bbedc66fff92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_489252ff-f627-407e-a099-4be8b522853d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_94b026a9-1e16-4b40-a027-bbedc66fff92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_d868870a-1d32-4d38-909c-12c3cbac588e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_489252ff-f627-407e-a099-4be8b522853d" xlink:to="loc_us-gaap_RestrictedStockMember_d868870a-1d32-4d38-909c-12c3cbac588e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_984d495e-8fdd-413a-8f46-18c3485f2c69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_489252ff-f627-407e-a099-4be8b522853d" xlink:to="loc_us-gaap_EmployeeStockMember_984d495e-8fdd-413a-8f46-18c3485f2c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f7f5b24-fdf6-4bbf-abb3-0122b9365d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_391fd9c3-2901-455a-ab23-ca0ba7691cb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f7f5b24-fdf6-4bbf-abb3-0122b9365d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_51899b5f-32cc-474f-8ab7-ba0a98da8fad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f7f5b24-fdf6-4bbf-abb3-0122b9365d2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_51899b5f-32cc-474f-8ab7-ba0a98da8fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_25ad4d3a-af52-47f9-99e8-d4183e881edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f7f5b24-fdf6-4bbf-abb3-0122b9365d2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_25ad4d3a-af52-47f9-99e8-d4183e881edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_14ffdf71-e567-4e9e-9223-01e7a5d710ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f7f5b24-fdf6-4bbf-abb3-0122b9365d2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_14ffdf71-e567-4e9e-9223-01e7a5d710ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_54e7215e-00e5-4201-b981-84c23998555b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f7f5b24-fdf6-4bbf-abb3-0122b9365d2e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_54e7215e-00e5-4201-b981-84c23998555b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_56bff2ed-d034-43bf-afb4-140a59479bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f7f5b24-fdf6-4bbf-abb3-0122b9365d2e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_56bff2ed-d034-43bf-afb4-140a59479bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_7b15a28d-bd7d-4124-bbb4-bf8ace62e79a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f7f5b24-fdf6-4bbf-abb3-0122b9365d2e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_7b15a28d-bd7d-4124-bbb4-bf8ace62e79a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfSharesAvailableForFuturePurchase_6db5f091-1635-46c1-9fc6-bcf8a95ec737" xlink:href="isee-20220630.xsd#isee_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfSharesAvailableForFuturePurchase"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f7f5b24-fdf6-4bbf-abb3-0122b9365d2e" xlink:to="loc_isee_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfSharesAvailableForFuturePurchase_6db5f091-1635-46c1-9fc6-bcf8a95ec737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_dca76859-5ac9-4575-9ebb-5235c80a688d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f7f5b24-fdf6-4bbf-abb3-0122b9365d2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_dca76859-5ac9-4575-9ebb-5235c80a688d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_b2836a8b-a715-4289-84bc-6f94bd3305c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f7f5b24-fdf6-4bbf-abb3-0122b9365d2e" xlink:to="loc_us-gaap_ProceedsFromStockPlans_b2836a8b-a715-4289-84bc-6f94bd3305c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/ShareBasedCompensationSummaryofShareBasedCompensationExpensebyAwardTypeDetails" xlink:type="simple" xlink:href="isee-20220630.xsd#ShareBasedCompensationSummaryofShareBasedCompensationExpensebyAwardTypeDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/ShareBasedCompensationSummaryofShareBasedCompensationExpensebyAwardTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_39d63243-b5dc-4079-b8d7-efbcf4b9a4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bdb5a29f-a9fd-4b46-8de8-96460910665c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_39d63243-b5dc-4079-b8d7-efbcf4b9a4b7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bdb5a29f-a9fd-4b46-8de8-96460910665c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7143c7b8-ddf5-42f6-bca4-c2ac350504df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bdb5a29f-a9fd-4b46-8de8-96460910665c" xlink:to="loc_us-gaap_AwardTypeAxis_7143c7b8-ddf5-42f6-bca4-c2ac350504df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22d5d6f1-294b-4f7b-a12c-79d799de327e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7143c7b8-ddf5-42f6-bca4-c2ac350504df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22d5d6f1-294b-4f7b-a12c-79d799de327e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_74109c0d-f1dd-4bfe-bf83-d48b03c792e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22d5d6f1-294b-4f7b-a12c-79d799de327e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_74109c0d-f1dd-4bfe-bf83-d48b03c792e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f8604877-9d71-4e4b-9d98-38be15abe7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22d5d6f1-294b-4f7b-a12c-79d799de327e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f8604877-9d71-4e4b-9d98-38be15abe7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_StockIncentive2013PlanMember_deaa1028-a9c5-4755-bd6f-a393814f33f7" xlink:href="isee-20220630.xsd#isee_StockIncentive2013PlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22d5d6f1-294b-4f7b-a12c-79d799de327e" xlink:to="loc_isee_StockIncentive2013PlanMember_deaa1028-a9c5-4755-bd6f-a393814f33f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1df4dece-de61-42b9-936d-a7f0a0f0fcda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bdb5a29f-a9fd-4b46-8de8-96460910665c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1df4dece-de61-42b9-936d-a7f0a0f0fcda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_237e504f-6412-40b6-b07b-ad9b3e7dadb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1df4dece-de61-42b9-936d-a7f0a0f0fcda" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_237e504f-6412-40b6-b07b-ad9b3e7dadb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/ShareBasedCompensationScheduleofAllocatedStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="isee-20220630.xsd#ShareBasedCompensationScheduleofAllocatedStockbasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/ShareBasedCompensationScheduleofAllocatedStockbasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5b84d50a-9180-4a7b-8a13-432a52af1145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b8702d58-76e4-406d-b8bd-285cc1965328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5b84d50a-9180-4a7b-8a13-432a52af1145" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b8702d58-76e4-406d-b8bd-285cc1965328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3bd9b3ae-291d-42b6-ac30-72406f2f8fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b8702d58-76e4-406d-b8bd-285cc1965328" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3bd9b3ae-291d-42b6-ac30-72406f2f8fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_947d75d3-9c49-4955-93b8-9b1ffd97b68b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3bd9b3ae-291d-42b6-ac30-72406f2f8fda" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_947d75d3-9c49-4955-93b8-9b1ffd97b68b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_10773138-8250-4343-8bea-560199cab38e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_947d75d3-9c49-4955-93b8-9b1ffd97b68b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_10773138-8250-4343-8bea-560199cab38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_e1d763f8-6826-459b-96bf-efe39be94df3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_947d75d3-9c49-4955-93b8-9b1ffd97b68b" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_e1d763f8-6826-459b-96bf-efe39be94df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d3442141-de63-4824-95a4-5508c778dfca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b8702d58-76e4-406d-b8bd-285cc1965328" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d3442141-de63-4824-95a4-5508c778dfca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_8586088e-a30c-4525-a70c-31db01d4e0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d3442141-de63-4824-95a4-5508c778dfca" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_8586088e-a30c-4525-a70c-31db01d4e0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="isee-20220630.xsd#ShareBasedCompensationSummaryofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7ee6d171-6f43-4bb9-af39-0df8b3231799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b5f302b0-31af-429f-a4d8-734c68c250da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7ee6d171-6f43-4bb9-af39-0df8b3231799" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b5f302b0-31af-429f-a4d8-734c68c250da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_adb3a3c0-7f91-4025-b1af-6661f061fa4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b5f302b0-31af-429f-a4d8-734c68c250da" xlink:to="loc_us-gaap_AwardTypeAxis_adb3a3c0-7f91-4025-b1af-6661f061fa4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c482caa7-9f68-45b5-8191-b170b9702c20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_adb3a3c0-7f91-4025-b1af-6661f061fa4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c482caa7-9f68-45b5-8191-b170b9702c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_337a5d54-ae19-42df-bd97-c5dbf6ed4279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c482caa7-9f68-45b5-8191-b170b9702c20" xlink:to="loc_us-gaap_EmployeeStockOptionMember_337a5d54-ae19-42df-bd97-c5dbf6ed4279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c1cec9fe-ad57-4a60-bf73-f363fa22291e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b5f302b0-31af-429f-a4d8-734c68c250da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c1cec9fe-ad57-4a60-bf73-f363fa22291e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d5660cc1-16f6-4955-92d3-9c24553b20b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c1cec9fe-ad57-4a60-bf73-f363fa22291e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d5660cc1-16f6-4955-92d3-9c24553b20b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ce8fa0ed-4b57-4715-9974-22ddc6331cae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d5660cc1-16f6-4955-92d3-9c24553b20b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ce8fa0ed-4b57-4715-9974-22ddc6331cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_63ec06d3-81aa-4544-9b8e-56e0bc4a7b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d5660cc1-16f6-4955-92d3-9c24553b20b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_63ec06d3-81aa-4544-9b8e-56e0bc4a7b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a1ae0771-1e16-4bc8-842d-9696a93c1786" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d5660cc1-16f6-4955-92d3-9c24553b20b6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a1ae0771-1e16-4bc8-842d-9696a93c1786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_507bb1c0-41a5-47fc-b539-bc8b629da9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d5660cc1-16f6-4955-92d3-9c24553b20b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_507bb1c0-41a5-47fc-b539-bc8b629da9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_577c775c-bf39-4a90-999f-c87ed4c572f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d5660cc1-16f6-4955-92d3-9c24553b20b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_577c775c-bf39-4a90-999f-c87ed4c572f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_bdd07d75-0810-4ff0-9895-fe338d3442ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c1cec9fe-ad57-4a60-bf73-f363fa22291e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_bdd07d75-0810-4ff0-9895-fe338d3442ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_e3846ee9-8f7d-4e58-abd6-5b1f8d3e31e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c1cec9fe-ad57-4a60-bf73-f363fa22291e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_e3846ee9-8f7d-4e58-abd6-5b1f8d3e31e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_eaa0898a-53bb-4ebe-a7ca-991d19f0d11a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c1cec9fe-ad57-4a60-bf73-f363fa22291e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_eaa0898a-53bb-4ebe-a7ca-991d19f0d11a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_878d7031-3b11-4a17-b44e-1dfa31039d42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_eaa0898a-53bb-4ebe-a7ca-991d19f0d11a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_878d7031-3b11-4a17-b44e-1dfa31039d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a04d9410-7de6-487f-a15c-ef1259578f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_eaa0898a-53bb-4ebe-a7ca-991d19f0d11a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a04d9410-7de6-487f-a15c-ef1259578f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_84ef497a-4058-4592-9e4e-3a68b70b00c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_eaa0898a-53bb-4ebe-a7ca-991d19f0d11a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_84ef497a-4058-4592-9e4e-3a68b70b00c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_667b27ee-08b2-46cc-87b9-f89f647980ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_eaa0898a-53bb-4ebe-a7ca-991d19f0d11a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_667b27ee-08b2-46cc-87b9-f89f647980ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d604de09-15f1-4ed6-9cf9-5593765c050f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_eaa0898a-53bb-4ebe-a7ca-991d19f0d11a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d604de09-15f1-4ed6-9cf9-5593765c050f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_45723d45-006c-4f1a-a27a-fccd6bca99d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c1cec9fe-ad57-4a60-bf73-f363fa22291e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_45723d45-006c-4f1a-a27a-fccd6bca99d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_bdee5860-46ea-417b-b46f-2af2f830ed2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c1cec9fe-ad57-4a60-bf73-f363fa22291e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_bdee5860-46ea-417b-b46f-2af2f830ed2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/ShareBasedCompensationSummaryofOutstandingRSUAwardsGrantedDetails" xlink:type="simple" xlink:href="isee-20220630.xsd#ShareBasedCompensationSummaryofOutstandingRSUAwardsGrantedDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/ShareBasedCompensationSummaryofOutstandingRSUAwardsGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_84ab74f1-ac21-406d-8749-44ee28ceda78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b3742ca7-1fc3-4ad5-a57d-7864e3b1a0cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_84ab74f1-ac21-406d-8749-44ee28ceda78" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b3742ca7-1fc3-4ad5-a57d-7864e3b1a0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_69f3784c-320f-46db-93b2-0ff234106133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b3742ca7-1fc3-4ad5-a57d-7864e3b1a0cf" xlink:to="loc_us-gaap_AwardTypeAxis_69f3784c-320f-46db-93b2-0ff234106133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_82bc184c-711a-4ed9-8b51-12ec8c50aef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_69f3784c-320f-46db-93b2-0ff234106133" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_82bc184c-711a-4ed9-8b51-12ec8c50aef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_b8cb357d-a032-4437-a5b5-c2ac70be6991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_82bc184c-711a-4ed9-8b51-12ec8c50aef4" xlink:to="loc_us-gaap_RestrictedStockMember_b8cb357d-a032-4437-a5b5-c2ac70be6991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6ac6107b-d3e8-4ae4-9766-360d8e91e516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b3742ca7-1fc3-4ad5-a57d-7864e3b1a0cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6ac6107b-d3e8-4ae4-9766-360d8e91e516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a5e0c196-e22b-4f5a-9202-614926c9368a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6ac6107b-d3e8-4ae4-9766-360d8e91e516" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a5e0c196-e22b-4f5a-9202-614926c9368a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_06765358-a8d5-4b56-b1e5-b7b3611f6a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a5e0c196-e22b-4f5a-9202-614926c9368a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_06765358-a8d5-4b56-b1e5-b7b3611f6a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f8a17e61-596d-4ce9-988c-edf6feeeeb83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a5e0c196-e22b-4f5a-9202-614926c9368a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f8a17e61-596d-4ce9-988c-edf6feeeeb83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_be086758-da29-4ab7-81b7-f9a2f7ded0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a5e0c196-e22b-4f5a-9202-614926c9368a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_be086758-da29-4ab7-81b7-f9a2f7ded0e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_131073b6-0869-40c4-a7fb-10114af1ac15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a5e0c196-e22b-4f5a-9202-614926c9368a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_131073b6-0869-40c4-a7fb-10114af1ac15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5f035dd9-c825-44a4-aa17-7d94d3aaaa28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a5e0c196-e22b-4f5a-9202-614926c9368a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5f035dd9-c825-44a4-aa17-7d94d3aaaa28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ShareBasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumber_0332e84c-9912-4e8b-b2dc-92ef80593749" xlink:href="isee-20220630.xsd#isee_ShareBasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6ac6107b-d3e8-4ae4-9766-360d8e91e516" xlink:to="loc_isee_ShareBasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumber_0332e84c-9912-4e8b-b2dc-92ef80593749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_32e594c3-2e1e-4bbb-afb5-366817bf414a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6ac6107b-d3e8-4ae4-9766-360d8e91e516" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_32e594c3-2e1e-4bbb-afb5-366817bf414a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_85b73e89-6dc2-481a-832f-cb4fd5e0319b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_32e594c3-2e1e-4bbb-afb5-366817bf414a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_85b73e89-6dc2-481a-832f-cb4fd5e0319b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e69f4fe8-f6dc-450e-b1e5-82e654e73e12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_32e594c3-2e1e-4bbb-afb5-366817bf414a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e69f4fe8-f6dc-450e-b1e5-82e654e73e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_fef986ba-0684-4377-ad16-bee201bcd8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_32e594c3-2e1e-4bbb-afb5-366817bf414a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_fef986ba-0684-4377-ad16-bee201bcd8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_941780f0-a644-4f8d-95f9-680c5afeca0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_32e594c3-2e1e-4bbb-afb5-366817bf414a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_941780f0-a644-4f8d-95f9-680c5afeca0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_14435063-1891-4266-bbda-efacef590317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_32e594c3-2e1e-4bbb-afb5-366817bf414a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_14435063-1891-4266-bbda-efacef590317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue_53f90181-8317-4b4e-97aa-31ef93b334eb" xlink:href="isee-20220630.xsd#isee_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6ac6107b-d3e8-4ae4-9766-360d8e91e516" xlink:to="loc_isee_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue_53f90181-8317-4b4e-97aa-31ef93b334eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="isee-20220630.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9552d2cd-3d46-4601-941b-b408ea194c49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_aea53536-a4fe-4eea-b581-fb20b4e57a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9552d2cd-3d46-4601-941b-b408ea194c49" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_aea53536-a4fe-4eea-b581-fb20b4e57a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="isee-20220630.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_435474c7-25f3-46e7-8637-3a30af745cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_fae2f521-8813-4943-ac25-d6ee8f442e33" xlink:href="isee-20220630.xsd#isee_ScheduleOfCommitmentsAndContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_435474c7-25f3-46e7-8637-3a30af745cc5" xlink:to="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_fae2f521-8813-4943-ac25-d6ee8f442e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MilestoneEventsAxis_9ac47fa3-5ab7-44ac-9a85-8529e7ca82fb" xlink:href="isee-20220630.xsd#isee_MilestoneEventsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_fae2f521-8813-4943-ac25-d6ee8f442e33" xlink:to="loc_isee_MilestoneEventsAxis_9ac47fa3-5ab7-44ac-9a85-8529e7ca82fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MilestoneEventsDomain_a02ab4bb-164f-4bc2-800c-d157bbfbda9a" xlink:href="isee-20220630.xsd#isee_MilestoneEventsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsAxis_9ac47fa3-5ab7-44ac-9a85-8529e7ca82fb" xlink:to="loc_isee_MilestoneEventsDomain_a02ab4bb-164f-4bc2-800c-d157bbfbda9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AchievementOfSpecifiedClinicalAndRegulatoryMilestonesMember_5f9b8153-a06a-4372-b4a1-f0ce5f2a4821" xlink:href="isee-20220630.xsd#isee_AchievementOfSpecifiedClinicalAndRegulatoryMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_a02ab4bb-164f-4bc2-800c-d157bbfbda9a" xlink:to="loc_isee_AchievementOfSpecifiedClinicalAndRegulatoryMilestonesMember_5f9b8153-a06a-4372-b4a1-f0ce5f2a4821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_FirstIndicationMember_0d5db2fc-51ae-4df0-8324-f87ea09d57e9" xlink:href="isee-20220630.xsd#isee_FirstIndicationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_a02ab4bb-164f-4bc2-800c-d157bbfbda9a" xlink:to="loc_isee_FirstIndicationMember_0d5db2fc-51ae-4df0-8324-f87ea09d57e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SecondandThirdIndicationMember_0f1ecf71-9877-42bf-a43a-e2bcfd9f1c77" xlink:href="isee-20220630.xsd#isee_SecondandThirdIndicationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_a02ab4bb-164f-4bc2-800c-d157bbfbda9a" xlink:to="loc_isee_SecondandThirdIndicationMember_0f1ecf71-9877-42bf-a43a-e2bcfd9f1c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SustainedDeliveryApplicationsMember_3e395bd1-165c-4260-86d8-915541a89395" xlink:href="isee-20220630.xsd#isee_SustainedDeliveryApplicationsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_a02ab4bb-164f-4bc2-800c-d157bbfbda9a" xlink:to="loc_isee_SustainedDeliveryApplicationsMember_3e395bd1-165c-4260-86d8-915541a89395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AchievementOfSpecifiedCommercialMilestonesMember_4eb9ea17-4d9c-41f1-830c-8158569c59ae" xlink:href="isee-20220630.xsd#isee_AchievementOfSpecifiedCommercialMilestonesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_a02ab4bb-164f-4bc2-800c-d157bbfbda9a" xlink:to="loc_isee_AchievementOfSpecifiedCommercialMilestonesMember_4eb9ea17-4d9c-41f1-830c-8158569c59ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SpecifiedClinicalMarketingApprovalandReimbursementApprovalMilestonesRelatedtoaLicensedProductMember_f7ea97ce-5571-400f-b76d-c8bab30abbec" xlink:href="isee-20220630.xsd#isee_SpecifiedClinicalMarketingApprovalandReimbursementApprovalMilestonesRelatedtoaLicensedProductMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_a02ab4bb-164f-4bc2-800c-d157bbfbda9a" xlink:to="loc_isee_SpecifiedClinicalMarketingApprovalandReimbursementApprovalMilestonesRelatedtoaLicensedProductMember_f7ea97ce-5571-400f-b76d-c8bab30abbec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SpecifiedCommercialSalesMilestonesRelatedtoaLicensedProductMember_d7630ba0-6af6-4431-b130-65e6eea88523" xlink:href="isee-20220630.xsd#isee_SpecifiedCommercialSalesMilestonesRelatedtoaLicensedProductMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_a02ab4bb-164f-4bc2-800c-d157bbfbda9a" xlink:to="loc_isee_SpecifiedCommercialSalesMilestonesRelatedtoaLicensedProductMember_d7630ba0-6af6-4431-b130-65e6eea88523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AchievementOfSpecifiedClinicalAndDevelopmentMilestonesMember_482d3e34-9138-44f4-8dd6-c51ee0336d28" xlink:href="isee-20220630.xsd#isee_AchievementOfSpecifiedClinicalAndDevelopmentMilestonesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_a02ab4bb-164f-4bc2-800c-d157bbfbda9a" xlink:to="loc_isee_AchievementOfSpecifiedClinicalAndDevelopmentMilestonesMember_482d3e34-9138-44f4-8dd6-c51ee0336d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AchievementOfSpecifiedCommercialSalesMilestonesMember_91cc23e7-f4f4-4a4d-8ed8-e4ab9b9f0960" xlink:href="isee-20220630.xsd#isee_AchievementOfSpecifiedCommercialSalesMilestonesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_a02ab4bb-164f-4bc2-800c-d157bbfbda9a" xlink:to="loc_isee_AchievementOfSpecifiedCommercialSalesMilestonesMember_91cc23e7-f4f4-4a4d-8ed8-e4ab9b9f0960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_fb0bc636-e33e-4cbc-b167-1a1fda4e50a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_fae2f521-8813-4943-ac25-d6ee8f442e33" xlink:to="loc_srt_CounterpartyNameAxis_fb0bc636-e33e-4cbc-b167-1a1fda4e50a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_754b934a-7d81-4769-929d-9821415294aa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_fb0bc636-e33e-4cbc-b167-1a1fda4e50a9" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_754b934a-7d81-4769-929d-9821415294aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ArchemixCorpMember_d6c9de6e-e6ec-47a6-a647-7d8974ac42b0" xlink:href="isee-20220630.xsd#isee_ArchemixCorpMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_754b934a-7d81-4769-929d-9821415294aa" xlink:to="loc_isee_ArchemixCorpMember_d6c9de6e-e6ec-47a6-a647-7d8974ac42b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_DelSiTechMember_841bf667-3dfd-4879-8038-33979334be61" xlink:href="isee-20220630.xsd#isee_DelSiTechMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_754b934a-7d81-4769-929d-9821415294aa" xlink:to="loc_isee_DelSiTechMember_841bf667-3dfd-4879-8038-33979334be61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_UniversityofFloridaResearchFoundationUFRFMember_71bad539-2f52-4cad-b9b7-8c085019a7c1" xlink:href="isee-20220630.xsd#isee_UniversityofFloridaResearchFoundationUFRFMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_754b934a-7d81-4769-929d-9821415294aa" xlink:to="loc_isee_UniversityofFloridaResearchFoundationUFRFMember_71bad539-2f52-4cad-b9b7-8c085019a7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_UniversityOfFloridaResearchFoundationUFRFAndUniversityOfPennsylvaniaPennMember_cbd4d81a-79b6-47f8-aa09-825937071568" xlink:href="isee-20220630.xsd#isee_UniversityOfFloridaResearchFoundationUFRFAndUniversityOfPennsylvaniaPennMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_754b934a-7d81-4769-929d-9821415294aa" xlink:to="loc_isee_UniversityOfFloridaResearchFoundationUFRFAndUniversityOfPennsylvaniaPennMember_cbd4d81a-79b6-47f8-aa09-825937071568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_UniversityOfMassachusettsUMassMember_39ad3240-00a2-44d8-a3d0-9c60a4c7a1d4" xlink:href="isee-20220630.xsd#isee_UniversityOfMassachusettsUMassMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_754b934a-7d81-4769-929d-9821415294aa" xlink:to="loc_isee_UniversityOfMassachusettsUMassMember_39ad3240-00a2-44d8-a3d0-9c60a4c7a1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3cc0db42-0b88-4208-abdb-9a7bb9d95953" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_fae2f521-8813-4943-ac25-d6ee8f442e33" xlink:to="loc_srt_ProductOrServiceAxis_3cc0db42-0b88-4208-abdb-9a7bb9d95953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e50cebd8-d799-47bd-8e59-c59c3bb20b65" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_3cc0db42-0b88-4208-abdb-9a7bb9d95953" xlink:to="loc_srt_ProductsAndServicesDomain_e50cebd8-d799-47bd-8e59-c59c3bb20b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_C5LicensedProductsMember_c283b3bc-38e4-474b-851a-956e41873cb9" xlink:href="isee-20220630.xsd#isee_C5LicensedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e50cebd8-d799-47bd-8e59-c59c3bb20b65" xlink:to="loc_isee_C5LicensedProductsMember_c283b3bc-38e4-474b-851a-956e41873cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ZimuraMember_4ad52778-47e3-4ef0-9e59-a6340c45d085" xlink:href="isee-20220630.xsd#isee_ZimuraMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e50cebd8-d799-47bd-8e59-c59c3bb20b65" xlink:to="loc_isee_ZimuraMember_4ad52778-47e3-4ef0-9e59-a6340c45d085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_PrimaryLicensedProductMember_2db997f9-ea93-49a2-b58f-efea1ebd84d5" xlink:href="isee-20220630.xsd#isee_PrimaryLicensedProductMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e50cebd8-d799-47bd-8e59-c59c3bb20b65" xlink:to="loc_isee_PrimaryLicensedProductMember_2db997f9-ea93-49a2-b58f-efea1ebd84d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_OtherLicensedProductMember_db2b5cf5-82bf-4394-8ff1-f5a0a4c066cc" xlink:href="isee-20220630.xsd#isee_OtherLicensedProductMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e50cebd8-d799-47bd-8e59-c59c3bb20b65" xlink:to="loc_isee_OtherLicensedProductMember_db2b5cf5-82bf-4394-8ff1-f5a0a4c066cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MiniCEP290Member_74c322c0-b000-46a8-8a27-c3979c7a9f41" xlink:href="isee-20220630.xsd#isee_MiniCEP290Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e50cebd8-d799-47bd-8e59-c59c3bb20b65" xlink:to="loc_isee_MiniCEP290Member_74c322c0-b000-46a8-8a27-c3979c7a9f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_GAProductMember_613fd5dc-af19-4f9e-874f-98b100a2c773" xlink:href="isee-20220630.xsd#isee_GAProductMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e50cebd8-d799-47bd-8e59-c59c3bb20b65" xlink:to="loc_isee_GAProductMember_613fd5dc-af19-4f9e-874f-98b100a2c773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_WetAMDProductMember_d563bcee-7fd2-4471-a985-d8a3329346c7" xlink:href="isee-20220630.xsd#isee_WetAMDProductMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e50cebd8-d799-47bd-8e59-c59c3bb20b65" xlink:to="loc_isee_WetAMDProductMember_d563bcee-7fd2-4471-a985-d8a3329346c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ce1664ec-8846-446e-bb41-d0f1d4cfa77b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_fae2f521-8813-4943-ac25-d6ee8f442e33" xlink:to="loc_srt_RangeAxis_ce1664ec-8846-446e-bb41-d0f1d4cfa77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6e5cd512-5a2c-4a24-8faa-d29abe581109" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ce1664ec-8846-446e-bb41-d0f1d4cfa77b" xlink:to="loc_srt_RangeMember_6e5cd512-5a2c-4a24-8faa-d29abe581109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b6ebb339-f868-4721-b22d-8e9bb52e7996" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6e5cd512-5a2c-4a24-8faa-d29abe581109" xlink:to="loc_srt_MaximumMember_b6ebb339-f868-4721-b22d-8e9bb52e7996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_2239798c-60d5-4d23-bfb2-3ee72ee95900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_fae2f521-8813-4943-ac25-d6ee8f442e33" xlink:to="loc_us-gaap_TypeOfArrangementAxis_2239798c-60d5-4d23-bfb2-3ee72ee95900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_c95bdef6-d8ad-4bca-bb4f-e2beaf55a9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_2239798c-60d5-4d23-bfb2-3ee72ee95900" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_c95bdef6-d8ad-4bca-bb4f-e2beaf55a9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAgreementTermsMember_4aa41fc7-dd10-4186-b37d-1fca8a9a177f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAgreementTermsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_c95bdef6-d8ad-4bca-bb4f-e2beaf55a9b5" xlink:to="loc_us-gaap_LicenseAgreementTermsMember_4aa41fc7-dd10-4186-b37d-1fca8a9a177f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2fa14d51-7979-4da3-845d-0fd28655aef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_fae2f521-8813-4943-ac25-d6ee8f442e33" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2fa14d51-7979-4da3-845d-0fd28655aef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_621059b0-dd8a-4b2a-9aea-4b9a0c7c18ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2fa14d51-7979-4da3-845d-0fd28655aef7" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_621059b0-dd8a-4b2a-9aea-4b9a0c7c18ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAgreementTermsMember_e8ee1162-593e-42b9-bf07-a0a2dca49b91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAgreementTermsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_621059b0-dd8a-4b2a-9aea-4b9a0c7c18ff" xlink:to="loc_us-gaap_LicenseAgreementTermsMember_e8ee1162-593e-42b9-bf07-a0a2dca49b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_RHOadRPLicenseAgreementMember_89be71c9-cd52-4548-9e24-35fe187dc589" xlink:href="isee-20220630.xsd#isee_RHOadRPLicenseAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_621059b0-dd8a-4b2a-9aea-4b9a0c7c18ff" xlink:to="loc_isee_RHOadRPLicenseAgreementMember_89be71c9-cd52-4548-9e24-35fe187dc589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_BEST1LicenseAgreementMember_42d261e2-9030-4bf3-b00d-b8ae6d359354" xlink:href="isee-20220630.xsd#isee_BEST1LicenseAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_621059b0-dd8a-4b2a-9aea-4b9a0c7c18ff" xlink:to="loc_isee_BEST1LicenseAgreementMember_42d261e2-9030-4bf3-b00d-b8ae6d359354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_59066c88-74c8-4955-8386-2507e8ab89a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_fae2f521-8813-4943-ac25-d6ee8f442e33" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_59066c88-74c8-4955-8386-2507e8ab89a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6f27122d-6caa-4858-bd8e-57e393b99974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_59066c88-74c8-4955-8386-2507e8ab89a8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6f27122d-6caa-4858-bd8e-57e393b99974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_3a4ad55e-1993-4bc7-894a-382e34ca870c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6f27122d-6caa-4858-bd8e-57e393b99974" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_3a4ad55e-1993-4bc7-894a-382e34ca870c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_e0ade422-36f3-4474-bfeb-01efc19bf17a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_fae2f521-8813-4943-ac25-d6ee8f442e33" xlink:to="loc_us-gaap_AssetAcquisitionAxis_e0ade422-36f3-4474-bfeb-01efc19bf17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_1a57c6d8-e626-42f7-ba5c-340dccb7e0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_e0ade422-36f3-4474-bfeb-01efc19bf17a" xlink:to="loc_us-gaap_AssetAcquisitionDomain_1a57c6d8-e626-42f7-ba5c-340dccb7e0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_Inception4Member_1831f422-a336-40cd-8332-68665d2786fa" xlink:href="isee-20220630.xsd#isee_Inception4Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_1a57c6d8-e626-42f7-ba5c-340dccb7e0d2" xlink:to="loc_isee_Inception4Member_1831f422-a336-40cd-8332-68665d2786fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_ded80fbf-1e46-4f7c-a369-85ff1c645439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_fae2f521-8813-4943-ac25-d6ee8f442e33" xlink:to="loc_us-gaap_LitigationStatusAxis_ded80fbf-1e46-4f7c-a369-85ff1c645439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_37881fac-b973-409e-8317-4d3c375b231b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_ded80fbf-1e46-4f7c-a369-85ff1c645439" xlink:to="loc_us-gaap_LitigationStatusDomain_37881fac-b973-409e-8317-4d3c375b231b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_dc04e2f5-d285-45d5-a20a-ddd432357e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_37881fac-b973-409e-8317-4d3c375b231b" xlink:to="loc_us-gaap_SettledLitigationMember_dc04e2f5-d285-45d5-a20a-ddd432357e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_CommitmentsAndContingenciesLineItems_b0c4acd2-8387-4072-9fc3-617c755aff65" xlink:href="isee-20220630.xsd#isee_CommitmentsAndContingenciesLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_fae2f521-8813-4943-ac25-d6ee8f442e33" xlink:to="loc_isee_CommitmentsAndContingenciesLineItems_b0c4acd2-8387-4072-9fc3-617c755aff65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AmountToBePaidOnAchievementOfMilestone_3e454a07-2caa-4719-ab24-64b81b6739a0" xlink:href="isee-20220630.xsd#isee_AmountToBePaidOnAchievementOfMilestone"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_CommitmentsAndContingenciesLineItems_b0c4acd2-8387-4072-9fc3-617c755aff65" xlink:to="loc_isee_AmountToBePaidOnAchievementOfMilestone_3e454a07-2caa-4719-ab24-64b81b6739a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_PaymentsForLicenseFees_41f30dd9-7202-44cb-90ac-957849c30a39" xlink:href="isee-20220630.xsd#isee_PaymentsForLicenseFees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_CommitmentsAndContingenciesLineItems_b0c4acd2-8387-4072-9fc3-617c755aff65" xlink:to="loc_isee_PaymentsForLicenseFees_41f30dd9-7202-44cb-90ac-957849c30a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_NumberOfLicensedProducts_68843886-ee54-48f7-8a3b-b8469c7ee78b" xlink:href="isee-20220630.xsd#isee_NumberOfLicensedProducts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_CommitmentsAndContingenciesLineItems_b0c4acd2-8387-4072-9fc3-617c755aff65" xlink:to="loc_isee_NumberOfLicensedProducts_68843886-ee54-48f7-8a3b-b8469c7ee78b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SharesIssuedForLicenseFees_3d920afd-ad83-42c9-a6b6-95f2b562fde1" xlink:href="isee-20220630.xsd#isee_SharesIssuedForLicenseFees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_CommitmentsAndContingenciesLineItems_b0c4acd2-8387-4072-9fc3-617c755aff65" xlink:to="loc_isee_SharesIssuedForLicenseFees_3d920afd-ad83-42c9-a6b6-95f2b562fde1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AssetAcquisitionContingentConsiderationArrangementsRangeOfOutcomesValueHigh_098ffefb-b7a8-4ae2-bf3c-71d569429650" xlink:href="isee-20220630.xsd#isee_AssetAcquisitionContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_CommitmentsAndContingenciesLineItems_b0c4acd2-8387-4072-9fc3-617c755aff65" xlink:to="loc_isee_AssetAcquisitionContingentConsiderationArrangementsRangeOfOutcomesValueHigh_098ffefb-b7a8-4ae2-bf3c-71d569429650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AssetAcquisitionClinicalAndMarketingApprovalMilestones_b9b0c5a3-4bec-4950-9282-1d04adddff9c" xlink:href="isee-20220630.xsd#isee_AssetAcquisitionClinicalAndMarketingApprovalMilestones"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_CommitmentsAndContingenciesLineItems_b0c4acd2-8387-4072-9fc3-617c755aff65" xlink:to="loc_isee_AssetAcquisitionClinicalAndMarketingApprovalMilestones_b9b0c5a3-4bec-4950-9282-1d04adddff9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AssetAcquisitionMilestonePaymentSharePriceBasisForCalculationTradingDays_0ea2c53a-f87b-45f7-910b-8d2d8a8123ee" xlink:href="isee-20220630.xsd#isee_AssetAcquisitionMilestonePaymentSharePriceBasisForCalculationTradingDays"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_CommitmentsAndContingenciesLineItems_b0c4acd2-8387-4072-9fc3-617c755aff65" xlink:to="loc_isee_AssetAcquisitionMilestonePaymentSharePriceBasisForCalculationTradingDays_0ea2c53a-f87b-45f7-910b-8d2d8a8123ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AssetAcquisitionContingentConsiderationArrangementsRangeOfOutcomesSharesIssuableHigh_9a9a04f3-bc0d-4ee6-b960-5aeef32fff76" xlink:href="isee-20220630.xsd#isee_AssetAcquisitionContingentConsiderationArrangementsRangeOfOutcomesSharesIssuableHigh"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_CommitmentsAndContingenciesLineItems_b0c4acd2-8387-4072-9fc3-617c755aff65" xlink:to="loc_isee_AssetAcquisitionContingentConsiderationArrangementsRangeOfOutcomesSharesIssuableHigh_9a9a04f3-bc0d-4ee6-b960-5aeef32fff76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AssetAcquisitionContingentConsiderationArrangementsContingentlyIssuableSharesAsAPercentageOfSharesOutstanding_ab7a610a-5c49-4b82-8889-2d97f8de9a55" xlink:href="isee-20220630.xsd#isee_AssetAcquisitionContingentConsiderationArrangementsContingentlyIssuableSharesAsAPercentageOfSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_CommitmentsAndContingenciesLineItems_b0c4acd2-8387-4072-9fc3-617c755aff65" xlink:to="loc_isee_AssetAcquisitionContingentConsiderationArrangementsContingentlyIssuableSharesAsAPercentageOfSharesOutstanding_ab7a610a-5c49-4b82-8889-2d97f8de9a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_LitigationStayPeriod_cfd88290-a1ce-4c67-983c-91fd7e02fda4" xlink:href="isee-20220630.xsd#isee_LitigationStayPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_CommitmentsAndContingenciesLineItems_b0c4acd2-8387-4072-9fc3-617c755aff65" xlink:to="loc_isee_LitigationStayPeriod_cfd88290-a1ce-4c67-983c-91fd7e02fda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_300f8cea-dd32-4c57-833e-956b36833140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_CommitmentsAndContingenciesLineItems_b0c4acd2-8387-4072-9fc3-617c755aff65" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_300f8cea-dd32-4c57-833e-956b36833140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/OperatingLeases" xlink:type="simple" xlink:href="isee-20220630.xsd#OperatingLeases"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/OperatingLeases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1ff37037-df14-4ed6-bf03-4067d2ab16f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_3476d90a-9bb9-470b-a0d0-b04899afb059" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1ff37037-df14-4ed6-bf03-4067d2ab16f5" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_3476d90a-9bb9-470b-a0d0-b04899afb059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/OperatingLeasesTables" xlink:type="simple" xlink:href="isee-20220630.xsd#OperatingLeasesTables"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/OperatingLeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f57797db-5e40-47b0-ba60-70e245e2802b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_03dfe731-6f95-40ca-8deb-0e815751ff64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f57797db-5e40-47b0-ba60-70e245e2802b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_03dfe731-6f95-40ca-8deb-0e815751ff64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/OperatingLeasesNarrativeDetails" xlink:type="simple" xlink:href="isee-20220630.xsd#OperatingLeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/OperatingLeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d2a91ec7-7926-4fc5-880d-2a432d7837ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_2734e4df-1d74-453e-9883-4c5e701f3f99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d2a91ec7-7926-4fc5-880d-2a432d7837ff" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_2734e4df-1d74-453e-9883-4c5e701f3f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1858c3c3-665f-41c4-8cf6-b14c6916137b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2734e4df-1d74-453e-9883-4c5e701f3f99" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1858c3c3-665f-41c4-8cf6-b14c6916137b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b8c96237-bea0-4ac4-9753-c64e11881b50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1858c3c3-665f-41c4-8cf6-b14c6916137b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b8c96237-bea0-4ac4-9753-c64e11881b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ParsippanyOfficeLeaseMember_8c3a4efc-5dbc-493a-9c0c-acd34a5a4873" xlink:href="isee-20220630.xsd#isee_ParsippanyOfficeLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b8c96237-bea0-4ac4-9753-c64e11881b50" xlink:to="loc_isee_ParsippanyOfficeLeaseMember_8c3a4efc-5dbc-493a-9c0c-acd34a5a4873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_2cad4e68-aa9e-4658-8820-c15c86f1ac1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2734e4df-1d74-453e-9883-4c5e701f3f99" xlink:to="loc_us-gaap_LeaseContractualTermAxis_2cad4e68-aa9e-4658-8820-c15c86f1ac1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_c9e366b3-9c73-40a6-9b7e-51f108afc5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermAxis_2cad4e68-aa9e-4658-8820-c15c86f1ac1b" xlink:to="loc_us-gaap_LeaseContractualTermDomain_c9e366b3-9c73-40a6-9b7e-51f108afc5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_CranburyOfficeSpaceLeaseMember_3d427281-2e7a-465c-ac79-b91609501a13" xlink:href="isee-20220630.xsd#isee_CranburyOfficeSpaceLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_c9e366b3-9c73-40a6-9b7e-51f108afc5c0" xlink:to="loc_isee_CranburyOfficeSpaceLeaseMember_3d427281-2e7a-465c-ac79-b91609501a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_09592977-6a78-4349-bab1-846735851c18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2734e4df-1d74-453e-9883-4c5e701f3f99" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_09592977-6a78-4349-bab1-846735851c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_d31d910a-c319-4f20-b216-9f5e0d6b1f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_09592977-6a78-4349-bab1-846735851c18" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_d31d910a-c319-4f20-b216-9f5e0d6b1f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_ee6c897d-ce06-4667-a4bf-d1c2e18cfdfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_09592977-6a78-4349-bab1-846735851c18" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_ee6c897d-ce06-4667-a4bf-d1c2e18cfdfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0539dcd1-02b5-4bf1-b233-1a464504c4c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_09592977-6a78-4349-bab1-846735851c18" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0539dcd1-02b5-4bf1-b233-1a464504c4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_24d98656-d7d4-4043-8adc-04f053b20f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_09592977-6a78-4349-bab1-846735851c18" xlink:to="loc_us-gaap_OperatingLeaseLiability_24d98656-d7d4-4043-8adc-04f053b20f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_OperatingLeaseWeightedAverageEstimatedIncrementalBorrowingRate_8efb789b-7fe0-4185-95c0-0454ce0d4e20" xlink:href="isee-20220630.xsd#isee_OperatingLeaseWeightedAverageEstimatedIncrementalBorrowingRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_09592977-6a78-4349-bab1-846735851c18" xlink:to="loc_isee_OperatingLeaseWeightedAverageEstimatedIncrementalBorrowingRate_8efb789b-7fe0-4185-95c0-0454ce0d4e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_5ea9a7ad-8a8c-4702-943e-b41f45a96c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_09592977-6a78-4349-bab1-846735851c18" xlink:to="loc_us-gaap_OperatingLeaseExpense_5ea9a7ad-8a8c-4702-943e-b41f45a96c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_f2b47a5a-12aa-4d86-9d8a-82a38e243723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_09592977-6a78-4349-bab1-846735851c18" xlink:to="loc_us-gaap_OperatingLeasePayments_f2b47a5a-12aa-4d86-9d8a-82a38e243723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_717f2514-c4f0-4dd9-83d3-dfed6372fbbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_09592977-6a78-4349-bab1-846735851c18" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_717f2514-c4f0-4dd9-83d3-dfed6372fbbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/OperatingLeasesOperatingLeaseLiabilityMaturitiesDetails" xlink:type="simple" xlink:href="isee-20220630.xsd#OperatingLeasesOperatingLeaseLiabilityMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/OperatingLeasesOperatingLeaseLiabilityMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_21a9a4a6-fbe4-447a-a9d6-cf873b005ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_be61f49a-ba8f-4e6a-b2a6-3e6a1522c374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_21a9a4a6-fbe4-447a-a9d6-cf873b005ce5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_be61f49a-ba8f-4e6a-b2a6-3e6a1522c374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_143f2b99-698b-4209-b230-9114d9d182f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_21a9a4a6-fbe4-447a-a9d6-cf873b005ce5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_143f2b99-698b-4209-b230-9114d9d182f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_22dbf906-3d77-47d4-8eb0-de460195c2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_21a9a4a6-fbe4-447a-a9d6-cf873b005ce5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_22dbf906-3d77-47d4-8eb0-de460195c2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4bc3ed73-1dee-4af8-bc3f-7f1d8b25b854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_21a9a4a6-fbe4-447a-a9d6-cf873b005ce5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4bc3ed73-1dee-4af8-bc3f-7f1d8b25b854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0917f98f-693c-4ebc-a256-8887aa945453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_21a9a4a6-fbe4-447a-a9d6-cf873b005ce5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0917f98f-693c-4ebc-a256-8887aa945453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_f2619a1d-df55-4123-bd06-cfc754c5768d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_21a9a4a6-fbe4-447a-a9d6-cf873b005ce5" xlink:to="loc_us-gaap_OperatingLeaseLiability_f2619a1d-df55-4123-bd06-cfc754c5768d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/OperatingLeasesOperatingLeaseLiabilityMaturitiesDetails_1" xlink:type="simple" xlink:href="isee-20220630.xsd#OperatingLeasesOperatingLeaseLiabilityMaturitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/OperatingLeasesOperatingLeaseLiabilityMaturitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ivericbio.com/role/SubsequentEvents" xlink:type="simple" xlink:href="isee-20220630.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_8cb7f7a2-42d8-4519-a22b-52ed1898709c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_98003d1a-9579-4c4c-937b-6db3d013c775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_8cb7f7a2-42d8-4519-a22b-52ed1898709c" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_98003d1a-9579-4c4c-937b-6db3d013c775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="isee-20220630.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_b18bb4fa-eae1-4d58-ab15-f1f4983fc360" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_e153c1e5-e8de-49e9-8123-fd2786fd53bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_b18bb4fa-eae1-4d58-ab15-f1f4983fc360" xlink:to="loc_us-gaap_SubsequentEventTable_e153c1e5-e8de-49e9-8123-fd2786fd53bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_261d85a2-8721-477e-92f8-fbe56960b946" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_e153c1e5-e8de-49e9-8123-fd2786fd53bb" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_261d85a2-8721-477e-92f8-fbe56960b946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_85928435-7411-427f-9323-f2fb40402aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_261d85a2-8721-477e-92f8-fbe56960b946" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_85928435-7411-427f-9323-f2fb40402aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_3d1abf16-01f5-4d93-b695-cd0560ff873c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_85928435-7411-427f-9323-f2fb40402aa5" xlink:to="loc_us-gaap_SubsequentEventMember_3d1abf16-01f5-4d93-b695-cd0560ff873c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4d670162-9424-4794-9dc1-c798ec9c5503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_e153c1e5-e8de-49e9-8123-fd2786fd53bb" xlink:to="loc_us-gaap_DebtInstrumentAxis_4d670162-9424-4794-9dc1-c798ec9c5503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5a0024b1-bb0f-48ef-9788-ae02088ebbd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_4d670162-9424-4794-9dc1-c798ec9c5503" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5a0024b1-bb0f-48ef-9788-ae02088ebbd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_A2022TermLoanMember_bf2a0c21-57de-40e3-904b-d8bb5b1a5a84" xlink:href="isee-20220630.xsd#isee_A2022TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5a0024b1-bb0f-48ef-9788-ae02088ebbd0" xlink:to="loc_isee_A2022TermLoanMember_bf2a0c21-57de-40e3-904b-d8bb5b1a5a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_86224bfc-94bc-4dcf-b281-a4bc381780fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_e153c1e5-e8de-49e9-8123-fd2786fd53bb" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_86224bfc-94bc-4dcf-b281-a4bc381780fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7804e8e9-42b0-4eb5-adc7-842ab9325a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_86224bfc-94bc-4dcf-b281-a4bc381780fe" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7804e8e9-42b0-4eb5-adc7-842ab9325a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_49e61d93-8783-48cf-9ea4-892850b772e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7804e8e9-42b0-4eb5-adc7-842ab9325a0f" xlink:to="loc_us-gaap_LineOfCreditMember_49e61d93-8783-48cf-9ea4-892850b772e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_8b23232b-869b-48d3-8402-193ac9b85dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7804e8e9-42b0-4eb5-adc7-842ab9325a0f" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_8b23232b-869b-48d3-8402-193ac9b85dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_fd86b9cd-346f-4dcb-a852-072c9a919aef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7804e8e9-42b0-4eb5-adc7-842ab9325a0f" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_fd86b9cd-346f-4dcb-a852-072c9a919aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_DebtTrancheAxis_1db899a3-d214-45ab-9d0a-fa11a1d8ed53" xlink:href="isee-20220630.xsd#isee_DebtTrancheAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_e153c1e5-e8de-49e9-8123-fd2786fd53bb" xlink:to="loc_isee_DebtTrancheAxis_1db899a3-d214-45ab-9d0a-fa11a1d8ed53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_DebtTrancheDomain_da44003b-3569-423c-a932-a18ee3e4f0fa" xlink:href="isee-20220630.xsd#isee_DebtTrancheDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DebtTrancheAxis_1db899a3-d214-45ab-9d0a-fa11a1d8ed53" xlink:to="loc_isee_DebtTrancheDomain_da44003b-3569-423c-a932-a18ee3e4f0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_TrancheOneMember_5481813e-fcae-44fd-b447-7a07167bb5ae" xlink:href="isee-20220630.xsd#isee_TrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DebtTrancheDomain_da44003b-3569-423c-a932-a18ee3e4f0fa" xlink:to="loc_isee_TrancheOneMember_5481813e-fcae-44fd-b447-7a07167bb5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_TrancheTwoMember_d01be796-6a06-42dc-8492-5d1c97f5f836" xlink:href="isee-20220630.xsd#isee_TrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DebtTrancheDomain_da44003b-3569-423c-a932-a18ee3e4f0fa" xlink:to="loc_isee_TrancheTwoMember_d01be796-6a06-42dc-8492-5d1c97f5f836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_TrancheThreeMember_f8ab445c-690c-465c-8b29-94fe91673fb3" xlink:href="isee-20220630.xsd#isee_TrancheThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DebtTrancheDomain_da44003b-3569-423c-a932-a18ee3e4f0fa" xlink:to="loc_isee_TrancheThreeMember_f8ab445c-690c-465c-8b29-94fe91673fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_TrancheFourMember_9aa9c199-e626-4a27-bf50-64cb16e109a6" xlink:href="isee-20220630.xsd#isee_TrancheFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DebtTrancheDomain_da44003b-3569-423c-a932-a18ee3e4f0fa" xlink:to="loc_isee_TrancheFourMember_9aa9c199-e626-4a27-bf50-64cb16e109a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_TrancheFiveMember_8077ad3a-0feb-4c9d-ab20-a29a49309624" xlink:href="isee-20220630.xsd#isee_TrancheFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DebtTrancheDomain_da44003b-3569-423c-a932-a18ee3e4f0fa" xlink:to="loc_isee_TrancheFiveMember_8077ad3a-0feb-4c9d-ab20-a29a49309624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_c6f91242-4f02-4cd4-bada-fd648688c402" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_e153c1e5-e8de-49e9-8123-fd2786fd53bb" xlink:to="loc_us-gaap_VariableRateAxis_c6f91242-4f02-4cd4-bada-fd648688c402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8bc08208-e948-4960-a8cb-2f0bfd952ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_c6f91242-4f02-4cd4-bada-fd648688c402" xlink:to="loc_us-gaap_VariableRateDomain_8bc08208-e948-4960-a8cb-2f0bfd952ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_f00c40f5-c3c3-4b68-a75c-ae61cb26f39e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrimeRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_8bc08208-e948-4960-a8cb-2f0bfd952ddb" xlink:to="loc_us-gaap_PrimeRateMember_f00c40f5-c3c3-4b68-a75c-ae61cb26f39e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3203ccdd-d021-4ea5-80fa-a9ef483df331" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_e153c1e5-e8de-49e9-8123-fd2786fd53bb" xlink:to="loc_srt_RangeAxis_3203ccdd-d021-4ea5-80fa-a9ef483df331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2aa83063-5ea4-4365-92ca-afbd84c14b8b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3203ccdd-d021-4ea5-80fa-a9ef483df331" xlink:to="loc_srt_RangeMember_2aa83063-5ea4-4365-92ca-afbd84c14b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1a197655-9664-4458-9f97-97c19d487b0f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2aa83063-5ea4-4365-92ca-afbd84c14b8b" xlink:to="loc_srt_MinimumMember_1a197655-9664-4458-9f97-97c19d487b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3641b9cc-cf77-4af0-a1bc-1ca2b0931ba2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2aa83063-5ea4-4365-92ca-afbd84c14b8b" xlink:to="loc_srt_MaximumMember_3641b9cc-cf77-4af0-a1bc-1ca2b0931ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_e6c2b22e-07af-4919-aff6-9f31a5df09f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_e153c1e5-e8de-49e9-8123-fd2786fd53bb" xlink:to="loc_us-gaap_SubsequentEventLineItems_e6c2b22e-07af-4919-aff6-9f31a5df09f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_da310631-b22a-472a-80be-ebef620c0e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e6c2b22e-07af-4919-aff6-9f31a5df09f3" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_da310631-b22a-472a-80be-ebef620c0e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_DebtInstrumentDrawnDownIncrements_f9a71d90-11bc-4d8b-9b49-90cfcefdfbb9" xlink:href="isee-20220630.xsd#isee_DebtInstrumentDrawnDownIncrements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e6c2b22e-07af-4919-aff6-9f31a5df09f3" xlink:to="loc_isee_DebtInstrumentDrawnDownIncrements_f9a71d90-11bc-4d8b-9b49-90cfcefdfbb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_DebtInstrumentLendersOptionToInvestInEquityFinancing_2f15ac71-7b56-4445-a145-39583841ed74" xlink:href="isee-20220630.xsd#isee_DebtInstrumentLendersOptionToInvestInEquityFinancing"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e6c2b22e-07af-4919-aff6-9f31a5df09f3" xlink:to="loc_isee_DebtInstrumentLendersOptionToInvestInEquityFinancing_2f15ac71-7b56-4445-a145-39583841ed74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ProceedsFromEquityFinancing_ee934ad5-7882-4d1f-9538-fb711df0cf03" xlink:href="isee-20220630.xsd#isee_ProceedsFromEquityFinancing"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e6c2b22e-07af-4919-aff6-9f31a5df09f3" xlink:to="loc_isee_ProceedsFromEquityFinancing_ee934ad5-7882-4d1f-9538-fb711df0cf03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8cc7bc10-7750-4ffe-b30f-b1902ab72c32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e6c2b22e-07af-4919-aff6-9f31a5df09f3" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8cc7bc10-7750-4ffe-b30f-b1902ab72c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_926c0511-7080-4c75-89a6-e6c4889a6c41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e6c2b22e-07af-4919-aff6-9f31a5df09f3" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_926c0511-7080-4c75-89a6-e6c4889a6c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_LineOfCreditFacilityInterestOnlyPaymentPeriod_eeccc588-68c4-4297-a13a-53a4d65236f4" xlink:href="isee-20220630.xsd#isee_LineOfCreditFacilityInterestOnlyPaymentPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e6c2b22e-07af-4919-aff6-9f31a5df09f3" xlink:to="loc_isee_LineOfCreditFacilityInterestOnlyPaymentPeriod_eeccc588-68c4-4297-a13a-53a4d65236f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_DebtInstrumentCovenantRevenueFromSaleMarketCapitalizationMaintainedWaiver_18e2958c-1907-4894-bfb9-15d4257f2208" xlink:href="isee-20220630.xsd#isee_DebtInstrumentCovenantRevenueFromSaleMarketCapitalizationMaintainedWaiver"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e6c2b22e-07af-4919-aff6-9f31a5df09f3" xlink:to="loc_isee_DebtInstrumentCovenantRevenueFromSaleMarketCapitalizationMaintainedWaiver_18e2958c-1907-4894-bfb9-15d4257f2208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_DebtInstrumentCovenantQualifiedCashWaiverPercent_2cf743ec-db37-4d93-9c07-38304befdf0a" xlink:href="isee-20220630.xsd#isee_DebtInstrumentCovenantQualifiedCashWaiverPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e6c2b22e-07af-4919-aff6-9f31a5df09f3" xlink:to="loc_isee_DebtInstrumentCovenantQualifiedCashWaiverPercent_2cf743ec-db37-4d93-9c07-38304befdf0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_DebtInstrumentEndTermChargesPercentage_27a585ed-1484-4f47-9245-fb31ae402d40" xlink:href="isee-20220630.xsd#isee_DebtInstrumentEndTermChargesPercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e6c2b22e-07af-4919-aff6-9f31a5df09f3" xlink:to="loc_isee_DebtInstrumentEndTermChargesPercentage_27a585ed-1484-4f47-9245-fb31ae402d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_DebtInstrumentPercentageOfPrepaymentPenaltyPrepaymentOccursPriorToFirstAnniversaryOfClosingDate_d096d33b-8f86-4f90-9d28-b86e60d1f397" xlink:href="isee-20220630.xsd#isee_DebtInstrumentPercentageOfPrepaymentPenaltyPrepaymentOccursPriorToFirstAnniversaryOfClosingDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e6c2b22e-07af-4919-aff6-9f31a5df09f3" xlink:to="loc_isee_DebtInstrumentPercentageOfPrepaymentPenaltyPrepaymentOccursPriorToFirstAnniversaryOfClosingDate_d096d33b-8f86-4f90-9d28-b86e60d1f397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_DebtInstrumentPercentageOfPrepaymentPenaltyPrepaymentOccursOnOrAfterTheFirstAnniversaryAndPriorToTheSecondAnniversaryOfTheClosingDate_610f81fe-562f-4495-938c-4d1d5fc511a3" xlink:href="isee-20220630.xsd#isee_DebtInstrumentPercentageOfPrepaymentPenaltyPrepaymentOccursOnOrAfterTheFirstAnniversaryAndPriorToTheSecondAnniversaryOfTheClosingDate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e6c2b22e-07af-4919-aff6-9f31a5df09f3" xlink:to="loc_isee_DebtInstrumentPercentageOfPrepaymentPenaltyPrepaymentOccursOnOrAfterTheFirstAnniversaryAndPriorToTheSecondAnniversaryOfTheClosingDate_610f81fe-562f-4495-938c-4d1d5fc511a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_DebtInstrumentPercentageOfPrepaymentPenaltyPrepaymentOccursOccursOnOrAfterTheSecondAnniversaryAndPriorToTheThirdAnniversaryOfTheClosingDate_2093c452-f2b3-4853-9a4b-c95c950565b6" xlink:href="isee-20220630.xsd#isee_DebtInstrumentPercentageOfPrepaymentPenaltyPrepaymentOccursOccursOnOrAfterTheSecondAnniversaryAndPriorToTheThirdAnniversaryOfTheClosingDate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e6c2b22e-07af-4919-aff6-9f31a5df09f3" xlink:to="loc_isee_DebtInstrumentPercentageOfPrepaymentPenaltyPrepaymentOccursOccursOnOrAfterTheSecondAnniversaryAndPriorToTheThirdAnniversaryOfTheClosingDate_2093c452-f2b3-4853-9a4b-c95c950565b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
